rfhg_150026.1

Basic information about the TSS

---

TSS ID: rfhg_150026.1 Species: human Chr: chr12		Start: 48941124 End: 48941124 Strand: -
Source datasets	PRJDB5282
Protocol	C1CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: EU832818:28 CU688492:28 GQ129444:28 AB528672:28 GeneID: 377 HGNC/MGI_ID: HGNC:654 UniProt_ID: Nearer transcript ids and distances: AF493882:29 BT006670:29 view more...

Gene_name: ADP ribosylation factor 3 Gene_symbol: ARF3 Gene_synonyms: Gene_source: HGNC:654

TATA-Box annotation

---

Distance to TSS:	-15577
Nearest PromoterID:	NM_001143782
Entrez ID:	51303
Nearest Unigene:	Hs.655103
Nearest Refseq:	NM_016594
Nearest Ensembl:	ENSG00000134285
Gene Name:	ADP ribosylation factor 3
Gene Alias:	FKBP19
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ARF3 p2@ARF3 p3@ARF3 p4@ARF3 p5@ARF3 p10@ARF3
Sample		p1@ARF3	p2@ARF3	p3@ARF3	p4@ARF3	p5@ARF3	p10@ARF3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	69.54	1.75	1.36	0.58	1.17	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	76.48	1.82	1.21	0.81	0.81	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	70.60	0.96	1.35	0.58	1.93	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	61.54	1.87	0.62	0.00	1.46	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	67.04	2.02	1.12	0.22	1.57	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	67.83	0.97	0.97	0.00	1.74	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	73.64	2.18	1.09	1.09	1.74	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	68.31	1.94	0.97	0.24	0.48	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	68.82	2.35	1.50	0.21	1.71	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	63.18	2.90	0.58	0.00	0.58	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	57.81	1.21	0.40	0.81	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	65.05	1.22	0.00	0.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	38.69	1.61	0.48	1.29	0.64	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	38.04	2.41	0.45	0.30	0.60	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	32.93	1.76	0.00	0.66	0.88	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	30.68	1.01	1.01	0.25	0.50	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	34.07	2.40	0.44	0.00	1.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	32.90	0.42	0.84	0.00	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	33.06	0.53	0.00	0.53	1.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	25.27	1.81	0.75	0.60	0.90	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	35.42	1.87	0.27	1.20	0.53	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	36.42	1.73	0.17	0.69	1.21	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	37.23	2.59	0.52	0.13	1.03	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	28.88	1.94	0.00	0.49	0.97	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	29.93	1.55	0.26	0.00	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	26.90	0.00	0.00	1.27	0.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	32.97	2.75	0.55	0.55	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	43.85	1.65	0.00	0.47	0.24	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	26.01	1.62	0.48	0.81	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	33.84	1.27	0.36	0.72	1.09	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	27.63	1.67	0.00	0.63	1.47	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	20.32	0.98	0.39	0.39	1.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	31.87	1.69	0.21	0.00	1.27	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	38.10	2.31	0.49	0.49	0.99	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	30.11	2.06	0.56	0.56	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	29.70	1.53	0.57	0.00	0.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	35.77	1.64	0.41	1.43	1.02	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	35.06	2.01	0.20	0.40	1.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	36.19	3.24	0.00	0.54	1.08	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	36.01	1.20	0.72	0.24	1.44	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	37.88	1.18	0.47	0.24	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	38.36	2.20	0.44	0.73	1.17	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	28.68	2.11	0.21	0.63	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	34.44	1.57	0.35	0.35	0.52	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	34.13	2.41	0.60	0.60	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	35.59	1.86	0.23	0.00	1.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	34.31	2.64	0.72	0.24	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	35.77	3.28	0.60	0.30	0.89	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	32.32	1.68	0.00	0.96	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	34.17	2.22	0.61	0.20	1.01	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	43.66	1.84	0.00	1.02	1.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	36.91	4.67	0.22	0.67	2.45	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	111.94	27.98	13.99	0.00	13.99	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	24.49	2.13	1.06	0.35	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	36.12	3.31	0.00	0.66	3.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	76.34	3.36	0.84	0.84	10.91	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	53.73	3.21	0.46	1.38	2.76	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	25.93	2.92	0.00	0.65	2.92	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	21.52	1.93	0.32	0.00	1.28	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	64.75	2.51	1.57	0.63	7.23	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	27.50	4.23	1.41	2.12	2.12	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	30.84	4.49	0.56	0.00	2.24	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	76.43	3.98	0.00	0.80	3.98	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	51.64	4.08	0.00	0.00	1.36	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	13.97	2.92	0.32	0.32	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	23.43	3.55	0.35	1.06	2.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	145.48	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	189.54	15.79	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	41.93	2.93	0.98	0.49	2.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	37.69	3.47	0.50	0.00	1.49	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	41.28	3.28	0.94	1.41	4.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	41.40	3.31	0.00	0.00	3.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	19.80	1.24	0.00	0.31	3.71	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	27.21	0.92	0.31	0.00	3.06	0.61
Adipocyte - breast, donor1	11376-118A8	62.09	2.85	0.63	0.79	0.32	0.00
Adipocyte - breast, donor2	11327-117E4	63.85	2.89	0.80	1.93	1.60	0.16
Adipocyte - omental, donor1	11473-119C6	65.01	2.67	1.78	1.40	0.25	0.00
Adipocyte - omental, donor2	11474-119C7	60.55	1.49	1.49	0.00	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	59.28	2.34	0.67	0.67	2.01	0.00
Adipocyte - perirenal, donor1	11476-119C9	59.97	5.74	0.64	0.64	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	26.39	0.00	1.10	1.10	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	82.65	1.81	3.16	1.35	0.90	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	52.83	1.04	2.95	1.74	0.17	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	108.15	5.28	2.54	2.93	0.98	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	71.55	2.57	1.80	1.03	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	68.86	3.62	0.28	1.39	1.12	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	90.52	1.76	2.35	1.76	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	113.41	4.75	2.01	2.73	0.64	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	89.08	2.58	2.58	2.26	0.97	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	48.52	3.73	0.53	1.07	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	64.55	0.56	0.56	0.00	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	109.38	3.74	0.42	0.42	1.25	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	70.58	1.00	2.51	2.26	1.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	68.39	3.27	1.64	1.96	1.64	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	77.94	2.13	1.83	1.52	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	130.39	10.83	0.66	0.66	0.66	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	155.27	8.96	2.87	0.72	1.79	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	68.29	3.59	1.20	0.00	3.59	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	64.41	3.78	1.08	0.36	1.08	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	48.53	1.67	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	65.33	3.08	1.23	0.82	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	85.93	3.09	2.29	0.46	0.57	0.23
Anulus Pulposus Cell, donor2	11463-119B5	59.76	4.90	2.45	2.45	0.98	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	69.64	5.84	0.45	0.45	5.39	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	77.71	3.47	0.00	0.00	2.17	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	34.24	2.14	2.14	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	66.96	5.38	0.60	0.90	2.39	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	70.82	3.79	0.00	0.00	3.79	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	48.19	1.32	0.66	0.00	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	65.30	1.30	0.97	0.97	2.27	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	68.45	3.88	0.97	1.46	1.94	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	57.01	1.78	1.19	0.59	1.19	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	78.72	3.39	2.64	2.26	2.26	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	67.49	5.81	1.45	1.45	2.90	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	36.36	6.27	1.25	0.00	3.76	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	65.24	4.12	1.32	1.15	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	46.40	4.09	1.36	0.00	1.36	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	35.59	2.56	0.45	0.45	0.30	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	76.08	4.82	0.54	2.14	3.21	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	72.17	7.37	0.94	1.89	1.32	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	62.54	5.35	0.80	0.80	2.41	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	50.72	1.95	0.00	0.00	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	71.82	6.80	1.00	2.49	1.33	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	46.83	1.20	1.20	0.00	2.40	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	74.34	3.54	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	73.07	7.55	1.37	1.72	0.86	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	58.73	4.19	0.00	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	60.68	6.31	1.46	0.49	2.91	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	72.85	7.97	1.52	0.76	2.28	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	36.34	4.85	0.00	0.00	2.42	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	76.95	3.42	0.57	1.14	1.71	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	73.75	5.34	0.43	1.50	1.07	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	46.20	2.06	1.03	0.00	1.29	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	61.47	5.16	0.94	0.94	0.94	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	63.02	5.47	0.64	0.00	1.29	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	49.94	2.14	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	59.08	5.85	1.17	1.17	4.09	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	63.23	5.12	0.00	1.20	0.60	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	39.20	7.13	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	67.64	5.09	1.02	1.53	4.07	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	72.08	6.11	1.27	2.04	2.80	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	35.58	3.18	0.64	0.64	1.91	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	55.67	4.32	0.86	0.86	0.86	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	67.95	5.29	0.85	1.06	0.64	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	44.66	3.77	0.58	0.00	0.00	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	73.69	4.72	0.00	1.89	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	69.34	4.07	0.85	1.19	0.51	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	30.11	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	69.71	4.23	0.00	2.11	2.11	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	69.26	3.65	1.93	1.50	0.86	1.93
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	48.73	0.60	0.60	0.00	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	69.25	5.10	1.46	1.46	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	76.32	5.98	0.46	1.61	1.61	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	53.56	2.55	2.55	2.55	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	41.19	3.81	0.51	1.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	81.13	5.57	1.24	1.65	0.41	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	50.49	4.90	0.31	0.92	1.22	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	76.00	4.30	0.48	1.91	3.82	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	64.30	5.99	0.89	1.55	1.11	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	48.83	1.53	0.00	0.00	3.05	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	59.82	3.88	0.55	1.11	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	72.82	5.30	1.06	2.65	0.79	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	54.52	3.27	0.36	0.00	1.45	1.09
Astrocyte - cerebellum, donor1	11500-119F6	121.22	6.39	3.19	2.58	0.61	0.00
Astrocyte - cerebellum, donor2	11580-120F5	104.41	8.73	3.08	3.59	1.54	0.34
Astrocyte - cerebellum, donor3	11661-122F5	88.09	4.82	1.05	0.42	0.42	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	84.71	3.83	3.83	0.00	0.70	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	90.27	6.63	2.26	1.46	2.75	0.97
Astrocyte - cerebral cortex, donor3	11392-118C6	87.26	6.56	1.64	2.54	0.89	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	140.26	6.54	5.05	5.39	1.61	0.57
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	137.31	10.65	3.76	5.26	1.50	0.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	124.15	8.31	4.21	6.03	0.91	0.34
Basophils, donor1	12241-129G9	51.78	6.02	4.18	3.14	0.26	0.00
Basophils, donor2	12242-129H1	55.20	8.30	4.69	4.33	0.00	0.72
Basophils, donor3	12243-129H2	61.74	6.47	5.29	3.38	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	90.34	1.29	1.94	1.94	0.43	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	131.21	6.86	3.20	1.83	2.29	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	57.39	0.00	0.00	0.00	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	139.34	4.39	0.63	1.88	1.88	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	123.73	6.24	2.08	2.70	1.04	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	73.92	2.30	1.15	1.38	0.92	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	58.12	1.26	1.08	1.08	1.08	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	63.28	4.53	3.71	3.71	0.41	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	106.20	9.78	6.99	3.26	0.93	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	35.81	25.26	0.96	1.28	0.00	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	68.19	6.20	5.07	2.25	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	52.34	5.75	1.86	2.97	1.30	0.00
CD14+ Monocytes, donor3	11381-118B4	64.76	4.61	2.85	1.76	0.66	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	100.76	7.36	3.11	0.85	0.57	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	84.53	6.44	4.17	4.17	0.76	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	110.46	8.88	3.29	2.63	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	74.88	6.79	1.59	2.31	1.01	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	51.60	6.64	0.30	1.21	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	69.65	6.87	2.13	1.66	0.95	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	54.57	4.85	0.84	1.84	0.84	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	43.89	5.24	0.83	1.38	0.55	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	54.79	3.97	0.50	0.25	0.25	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	70.49	5.48	1.76	1.17	1.76	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	51.28	5.34	2.85	1.07	0.18	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	61.15	6.75	1.96	1.52	0.22	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	45.19	2.11	1.64	0.70	0.70	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	52.27	4.22	1.06	0.53	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	35.50	3.33	1.11	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	65.60	5.80	1.78	1.64	0.59	0.74
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	44.10	4.99	0.60	0.40	0.40	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	43.51	4.37	1.04	0.62	0.83	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	55.37	6.18	1.14	1.37	1.37	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	40.49	3.85	0.68	1.13	0.45	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	50.19	3.49	1.75	1.31	0.87	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	85.27	5.38	1.88	1.88	2.15	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	74.32	6.28	1.92	1.74	0.35	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	83.74	5.89	1.68	0.42	1.68	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	53.64	4.59	1.47	1.10	1.10	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	45.79	5.64	1.41	1.41	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	40.80	3.95	2.63	0.88	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	62.60	5.06	1.39	1.92	0.35	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	63.93	4.83	1.12	1.86	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	72.86	8.62	2.37	1.72	1.08	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	57.74	2.87	1.23	2.05	0.82	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	45.20	3.71	1.16	0.93	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	46.86	3.48	0.46	1.16	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	49.26	2.18	2.40	1.53	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	58.21	5.31	5.31	1.62	0.92	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	45.49	3.68	2.38	0.43	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	69.76	7.79	2.96	2.18	0.62	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	77.19	5.76	2.27	1.57	0.70	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	97.88	11.59	2.68	1.11	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	34.45	0.51	3.57	1.79	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	36.89	1.32	4.39	1.98	0.44	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	40.64	2.11	3.16	1.47	0.21	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	36.58	2.03	8.13	4.06	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	37.29	0.68	4.07	4.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	35.21	1.04	8.28	5.18	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	40.51	1.60	8.53	4.80	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	43.96	1.61	5.90	2.14	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	33.69	2.11	5.62	2.11	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	23.53	0.78	5.49	6.27	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	36.91	1.32	7.91	3.95	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	22.19	1.64	4.11	4.11	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	23.94	0.73	1.45	2.18	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	21.20	0.50	1.01	4.54	0.50	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	8.08	0.40	0.81	0.40	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	6.79	1.20	0.80	0.40	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	14.06	11.04	1.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	37.64	14.61	3.37	1.12	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	51.85	18.41	2.25	3.01	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	43.52	15.56	2.03	1.35	0.45	0.00
CD4+ T Cells, donor1	11225-116C1	33.92	4.28	4.64	1.79	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	35.52	3.67	4.29	2.45	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	31.72	4.88	5.79	2.13	0.30	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	51.81	4.59	1.53	1.02	0.77	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	41.78	8.53	2.47	0.45	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	42.26	4.60	2.01	1.15	0.57	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	23.70	0.95	2.84	1.42	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	21.07	1.40	1.40	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	19.78	3.30	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	46.24	3.90	2.60	1.30	0.72	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	42.87	4.74	2.71	1.86	1.36	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	37.72	3.87	1.93	2.26	0.97	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	26.90	3.14	2.69	0.90	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	27.25	2.10	4.19	2.45	0.00	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	33.00	3.52	3.08	1.32	1.32	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	41.32	6.75	1.69	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	30.33	4.99	1.04	0.83	0.62	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	26.40	5.35	2.34	0.00	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	25.02	1.63	3.26	1.90	0.82	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	32.16	1.61	3.22	2.14	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	35.86	3.59	0.00	0.00	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	57.48	9.46	2.60	1.67	0.74	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	49.17	6.07	2.60	1.95	0.22	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	43.50	5.46	4.62	0.84	0.42	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	23.26	4.55	1.01	0.51	0.51	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	25.13	2.17	2.60	1.30	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	42.27	7.84	2.61	0.00	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	53.45	5.94	7.42	4.95	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	48.93	7.39	6.46	1.85	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	23.73	6.98	5.58	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	61.20	10.25	7.75	4.15	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	71.41	9.08	12.76	6.63	0.98	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	47.74	0.00	1.54	4.62	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	50.49	9.31	8.95	3.94	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	52.63	16.62	6.92	8.31	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	38.31	2.29	5.57	1.96	0.33	0.00
CD8+ T Cells, donor2	11307-117C2	37.54	6.01	5.63	3.00	1.88	0.00
CD8+ T Cells, donor3	11383-118B6	35.10	8.08	6.06	3.79	0.50	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	85.79	4.82	1.15	0.92	1.84	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	85.31	4.79	1.92	0.96	1.44	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	74.42	4.65	1.09	0.55	1.92	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	64.25	4.20	1.20	0.00	3.90	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	84.23	4.80	0.72	1.20	1.44	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	98.46	6.37	1.14	0.45	1.59	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	96.47	5.00	1.52	0.43	1.52	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	88.70	3.95	1.05	0.53	2.63	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	102.48	4.46	1.41	0.70	1.64	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	108.07	5.43	1.51	0.91	3.32	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	88.02	4.65	1.16	1.45	2.61	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	100.45	5.33	1.33	0.53	2.13	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	84.49	3.94	1.31	1.75	1.31	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	89.26	4.55	1.37	1.82	0.91	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	67.87	6.71	0.75	1.49	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	98.68	5.76	0.36	0.00	1.44	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	89.19	4.89	1.15	0.86	2.01	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	90.27	3.30	1.41	0.94	1.18	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	105.85	2.85	2.22	0.95	3.17	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	84.58	5.84	0.62	0.31	0.62	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	98.10	2.56	2.89	0.64	1.28	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	87.20	2.68	0.38	0.38	2.29	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	93.01	3.94	1.97	0.79	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	80.94	3.78	1.51	1.51	2.27	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	85.92	1.61	0.80	0.80	1.61	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	78.34	6.99	1.40	0.70	2.10	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	103.18	5.01	1.00	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	65.80	3.66	1.83	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	60.77	4.94	1.98	1.98	1.98	0.00
Cardiac Myocyte, donor3	11686-122I3	69.98	5.68	1.16	1.79	0.32	0.00
Chondrocyte - de diff, donor1	11261-116G1	56.51	3.81	2.77	1.73	0.69	0.00
Chondrocyte - de diff, donor2	11338-117F6	51.17	5.69	2.13	1.78	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	52.91	2.84	1.14	1.25	0.80	0.00
Chondrocyte - re diff, donor2	11339-117F7	90.42	5.37	1.79	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	57.83	2.43	0.81	1.21	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	102.36	6.66	2.64	1.38	1.15	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	80.38	5.77	1.28	2.35	1.50	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	87.26	6.28	2.57	1.68	1.15	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	187.99	9.35	10.18	7.43	1.19	0.28
Corneal Epithelial Cells, donor1	11526-119I5	128.89	3.29	2.63	1.76	0.66	0.00
Corneal Epithelial Cells, donor2	11606-120I4	119.45	2.28	1.14	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	96.12	2.81	1.53	2.05	0.77	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	98.07	3.96	1.82	0.99	0.66	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	90.21	4.73	1.58	1.89	1.26	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	86.27	3.45	6.90	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	82.40	5.62	2.16	1.84	1.73	0.54
Dendritic Cells - plasmacytoid, donor1	11228-116C4	91.22	10.25	4.10	2.05	0.68	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	90.75	9.79	3.92	0.00	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	101.14	15.49	3.87	1.94	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	71.71	12.34	3.00	2.33	0.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	76.28	11.15	3.52	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	79.18	11.88	1.70	1.70	1.13	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	76.67	12.98	2.36	1.97	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	85.81	17.45	2.33	1.75	1.16	0.00
Endothelial Cells - Artery, donor2	11341-117F9	88.23	20.23	2.12	3.29	2.35	0.47
Endothelial Cells - Artery, donor3	11413-118E9	82.22	16.30	3.51	2.63	0.88	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	56.74	11.30	1.99	1.11	0.44	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	70.89	15.21	2.74	3.04	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	59.48	24.53	0.85	1.97	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	82.31	18.42	4.16	2.67	0.89	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	61.96	14.06	0.00	1.56	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	51.75	15.03	1.70	2.55	0.85	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	95.63	26.01	2.00	0.80	1.20	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	79.14	13.10	3.67	2.62	4.72	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	89.71	19.13	2.48	2.24	1.62	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	63.01	14.77	0.87	1.30	0.22	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	88.18	20.76	2.08	2.56	1.10	0.24
Endothelial Cells - Vein, donor1	11267-116G7	84.18	13.65	2.28	3.41	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	76.14	14.67	2.79	2.10	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	78.35	16.49	1.88	2.20	1.57	0.31
Eosinophils, donor1	12244-129H3	76.23	0.00	15.25	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	136.97	21.45	3.30	9.90	1.65	0.00
Eosinophils, donor3	12246-129H5	103.44	28.53	7.13	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	93.33	1.95	1.22	1.47	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	104.01	0.00	0.00	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	81.34	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	58.70	2.87	0.82	0.00	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	45.44	2.85	0.88	0.33	2.63	0.33
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	43.44	1.41	1.30	0.65	2.82	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	85.50	6.06	1.33	0.97	1.21	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	105.08	7.78	2.73	3.41	1.09	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	87.22	5.38	1.37	2.11	1.16	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	74.57	1.84	2.11	3.95	0.79	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	78.73	5.32	1.99	2.66	0.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	80.29	7.26	1.81	1.81	1.81	0.91
Fibroblast - Cardiac, donor2	11345-117G4	121.27	5.31	1.52	0.76	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	85.96	8.99	1.26	1.89	1.10	0.63
Fibroblast - Cardiac, donor4	11452-119A3	76.69	6.67	1.52	2.73	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	57.23	6.22	2.16	2.03	0.89	0.38
Fibroblast - Cardiac, donor6	11460-119B2	66.40	4.70	1.52	1.21	0.45	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	126.62	7.91	2.01	1.88	0.40	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	63.42	2.16	0.00	1.73	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	55.66	4.39	2.93	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	109.32	4.84	1.85	1.38	0.92	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	58.34	2.04	0.85	1.02	0.34	0.00
Fibroblast - Dermal, donor1	11269-116G9	66.44	0.70	1.64	1.17	0.70	0.23
Fibroblast - Dermal, donor2	11346-117G5	90.09	1.89	2.83	0.94	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	75.31	2.90	2.18	2.90	1.57	0.24
Fibroblast - Dermal, donor4	11450-119A1	60.82	2.71	2.15	2.03	1.24	0.11
Fibroblast - Dermal, donor5	11454-119A5	59.84	2.97	1.05	1.40	1.92	0.35
Fibroblast - Dermal, donor6	11458-119A9	68.38	2.27	1.62	1.95	1.46	0.00
Fibroblast - Gingival, donor1	11237-116D4	85.58	4.16	1.67	2.08	0.21	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	88.03	3.41	1.05	1.83	0.52	0.00
Fibroblast - Gingival, donor2	11318-117D4	75.78	4.22	2.11	2.24	1.05	0.26
Fibroblast - Gingival, donor3	11394-118C8	72.52	2.90	2.80	1.55	0.77	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	88.31	4.16	5.19	2.08	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	61.85	2.64	1.59	0.70	1.94	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	87.15	4.05	1.25	0.78	0.31	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	76.40	3.25	1.22	1.08	0.54	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	80.46	7.06	1.06	0.35	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	76.34	3.66	1.61	0.88	0.44	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	80.86	3.95	1.09	0.95	0.95	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	76.57	3.84	1.21	0.88	0.33	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	66.47	2.49	0.88	1.17	0.29	0.00
Fibroblast - Lung, donor1	11270-116H1	66.61	1.36	2.72	2.72	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	65.65	2.98	1.49	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	96.23	6.54	2.74	2.74	0.84	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	213.25	3.33	2.50	0.83	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	85.32	2.80	0.00	2.80	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	86.20	3.36	1.12	0.84	1.40	0.28
Fibroblast - Mammary, donor1	11540-120B1	161.58	8.93	2.44	1.22	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	99.86	7.99	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	142.95	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	80.11	4.07	2.52	2.13	0.39	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	95.26	5.76	1.97	2.58	2.73	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	97.61	6.12	2.45	6.12	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	80.52	4.96	1.91	1.14	0.76	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	84.24	2.97	1.89	3.24	0.54	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	67.73	4.87	1.97	1.51	0.81	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	69.97	6.52	1.77	1.77	0.99	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	170.68	8.94	3.05	2.44	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	86.87	4.68	1.34	1.34	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	56.54	3.56	0.79	0.40	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	106.76	4.96	1.98	2.18	1.19	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	63.05	3.37	1.42	0.71	0.36	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	90.26	4.93	1.18	0.99	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	68.90	2.71	1.81	2.71	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	101.15	3.78	3.45	1.40	0.76	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	108.82	5.57	2.02	1.52	0.76	0.00
Fibroblast - skin normal, donor1	11553-120C5	85.98	3.28	2.63	0.66	0.49	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	62.36	5.01	2.01	1.60	0.60	0.20
Fibroblast - skin normal, donor2	11561-120D4	109.20	7.33	1.51	1.00	0.70	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	106.99	4.53	2.12	3.02	1.51	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	74.31	2.98	1.08	1.08	0.50	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	99.32	5.98	1.54	1.54	0.34	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	91.96	4.60	1.64	1.64	0.99	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	122.29	8.42	3.41	1.92	1.49	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	100.03	6.24	2.70	1.01	1.18	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	67.12	3.92	1.10	1.10	4.23	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	132.96	44.32	22.16	0.00	44.32	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	120.27	2.61	1.74	1.74	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	102.45	3.81	2.25	1.39	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	100.71	8.07	3.64	1.30	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	111.15	8.69	3.83	2.30	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	107.18	3.83	2.30	0.00	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	113.58	4.47	1.28	0.64	2.55	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	134.36	9.70	2.57	2.57	2.28	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	94.58	6.89	2.48	1.93	1.38	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	89.50	4.79	1.37	3.65	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	103.82	10.70	2.38	1.59	1.59	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	78.24	4.49	1.85	1.59	0.53	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	56.42	5.87	1.30	1.30	0.98	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	133.55	9.73	1.33	1.33	2.65	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	175.95	9.04	2.12	2.26	3.11	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	137.92	8.99	2.46	1.60	2.09	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	154.19	8.33	1.88	0.81	1.61	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	154.99	11.77	2.85	1.12	2.60	0.50
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	232.42	15.64	4.01	1.94	3.74	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	184.40	14.84	2.03	2.44	3.46	1.22
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	88.99	8.90	1.60	1.60	0.23	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	139.76	8.35	1.87	0.37	1.74	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	158.03	12.02	3.28	2.62	1.31	1.31
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	93.37	6.50	0.89	0.89	0.89	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	132.89	7.63	2.23	0.95	2.38	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	118.86	12.96	3.13	2.46	1.56	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	81.26	6.45	0.81	1.21	2.62	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	122.99	9.67	1.53	0.85	2.88	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	141.88	13.74	2.04	1.06	0.80	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	79.81	8.43	0.73	0.83	0.31	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	86.58	7.51	1.02	0.17	0.51	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	95.16	6.86	0.77	1.33	1.00	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	109.40	10.32	1.33	1.08	0.58	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	120.88	7.96	1.84	0.41	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	72.41	7.22	0.62	1.03	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	88.66	6.46	0.58	0.81	0.58	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	87.72	9.51	0.67	1.83	1.17	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	66.57	5.73	0.44	0.66	1.10	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	93.10	8.24	0.86	0.37	2.46	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	87.21	8.92	1.46	1.95	1.30	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	54.52	3.21	0.64	0.64	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	85.47	6.06	0.85	0.57	1.61	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	74.66	6.96	0.63	0.16	0.79	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	66.60	5.78	0.30	0.30	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	89.48	8.36	1.25	0.94	1.15	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	71.36	6.15	0.44	0.44	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	74.35	6.73	0.28	1.40	0.56	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	95.83	8.52	1.11	0.74	0.37	0.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	75.14	6.15	0.53	1.07	1.60	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	86.91	7.19	0.92	1.22	0.92	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	107.26	8.81	1.94	1.55	1.04	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	92.71	5.42	1.36	1.36	1.08	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	82.77	7.74	0.18	1.84	1.29	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	86.41	5.26	0.88	1.32	1.10	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	114.05	11.90	1.98	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	72.42	7.52	0.40	1.06	1.19	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	67.59	6.46	1.01	0.81	1.01	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	193.16	14.74	2.80	3.05	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	235.09	14.33	4.18	2.59	2.19	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	141.90	9.24	1.85	1.39	1.54	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	216.65	11.66	2.05	1.64	1.23	1.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	122.04	10.95	2.19	1.25	0.31	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	122.06	8.76	1.41	0.28	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	144.36	7.84	1.38	0.92	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	160.86	7.42	4.95	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	186.06	13.15	2.71	1.16	1.55	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	152.42	12.84	3.21	1.60	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	144.32	5.22	1.74	0.00	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	156.23	11.07	1.30	1.63	1.30	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	149.07	11.12	2.06	1.24	4.12	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	86.64	6.66	0.00	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	122.21	6.99	1.40	1.12	1.40	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	125.51	7.84	2.29	0.98	0.65	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	122.47	8.39	0.84	0.00	2.52	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	135.50	8.27	2.23	1.27	0.95	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	136.20	7.81	3.40	2.38	1.02	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	102.32	6.26	0.00	0.00	4.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	123.70	8.59	0.00	0.57	1.72	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	107.44	5.33	1.78	0.59	0.00	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	121.98	8.47	0.00	3.39	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	137.10	7.87	1.24	1.24	1.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	123.35	9.44	1.15	1.38	1.61	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	126.44	5.27	0.00	0.00	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	103.79	6.92	0.77	1.15	1.54	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	90.95	6.52	0.98	1.30	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	63.54	1.34	0.67	0.00	1.34	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	110.19	3.85	1.16	0.77	1.16	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	107.84	5.82	1.03	0.68	1.37	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	54.67	7.45	0.00	0.00	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	67.00	2.83	1.42	0.00	0.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	83.89	4.22	0.60	0.60	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	78.34	4.58	0.51	0.51	1.53	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	91.73	5.18	0.00	1.20	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	72.52	4.93	1.48	0.00	0.99	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	62.56	4.72	1.18	0.00	1.18	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	70.01	2.92	0.58	0.00	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	67.59	4.39	0.44	1.32	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	61.88	2.54	0.85	0.00	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	78.20	5.37	0.00	0.00	1.19	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	80.07	4.85	0.49	0.97	1.94	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	69.62	4.57	2.28	1.14	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	74.43	2.91	2.08	0.83	1.66	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	94.45	9.00	1.12	1.12	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	39.96	2.22	1.90	0.95	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	46.37	0.84	1.25	0.84	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	88.54	3.71	1.62	1.28	1.97	0.70
Hep-2 cells mock treated, biol_rep2	11899-125E9	102.80	2.03	2.87	1.52	1.35	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	95.78	2.50	1.59	1.37	0.68	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	91.38	2.62	2.40	0.98	1.97	0.98
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	106.81	3.22	1.29	1.50	1.07	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	95.37	3.01	1.51	1.51	1.29	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	90.79	2.62	1.25	1.99	1.12	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	87.66	3.95	2.06	0.34	2.23	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	92.59	2.56	2.56	1.92	1.28	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	62.12	11.19	2.80	3.92	1.12	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	96.95	13.85	1.30	1.73	2.16	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	37.01	10.58	0.00	2.64	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	101.94	5.64	1.06	2.82	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	102.44	8.72	1.45	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	58.40	6.64	1.05	1.05	0.87	0.17
Hepatocyte, donor1	11523-119I2	47.21	1.21	0.00	2.42	0.00	0.00
Hepatocyte, donor2	11603-120I1	72.18	0.00	0.00	3.23	0.00	0.00
Hepatocyte, donor3	11684-122I1	52.15	4.29	0.00	1.23	0.61	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	35.25	7.18	1.31	0.65	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	160.27	5.24	2.80	1.75	1.22	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	74.37	7.96	1.78	1.23	0.27	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	66.86	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	60.08	0.00	13.35	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	47.07	0.00	1.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	80.09	5.01	2.50	7.51	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	0.00	0.00	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	48.70	2.56	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	45.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	56.85	3.25	0.00	3.25	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	75.03	1.67	0.00	3.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	36.31	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	64.85	1.32	3.97	1.32	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	59.87	1.11	0.00	2.22	2.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	57.62	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	48.50	3.15	0.63	1.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	64.96	3.09	3.09	6.19	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	69.13	2.58	0.65	1.94	3.23	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	59.57	6.44	1.61	1.61	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	61.93	2.44	2.44	0.81	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	69.27	2.10	2.52	0.42	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	79.56	2.41	3.21	0.80	1.61	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	56.32	4.62	2.77	1.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	66.56	1.89	0.00	0.94	0.94	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	62.58	3.63	0.91	1.81	1.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	88.24	1.08	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	78.77	3.81	7.62	5.08	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	81.62	1.28	0.64	0.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	74.73	3.65	3.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	72.83	0.71	2.14	0.00	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	89.59	3.32	0.00	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	64.51	3.09	2.16	0.93	0.93	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	64.97	3.51	1.76	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	50.29	6.29	3.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	59.80	4.87	0.70	2.78	1.39	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	68.61	2.21	0.00	2.21	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	74.57	3.24	0.00	6.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	61.91	0.00	0.00	1.74	1.74	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	47.25	0.00	6.75	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	52.27	3.48	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	56.54	1.07	2.13	4.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	76.20	1.39	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	62.69	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	60.75	0.92	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	54.46	0.00	3.03	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	0.00	0.00	0.00	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	38.07	1.06	3.17	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	131.70	3.67	1.47	1.55	0.33	0.08
Keratinocyte - epidermal, donor2	11349-117G8	57.39	2.93	1.76	1.17	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	104.50	2.93	1.23	1.61	0.66	0.28
Keratinocyte - oral, donor1	11251-116E9	98.31	2.95	2.27	1.93	1.02	0.11
Keratocytes, donor1	11527-119I6	137.88	5.16	2.41	0.69	1.03	0.00
Keratocytes, donor2	11607-120I5	108.98	1.17	0.00	3.52	1.17	0.00
Keratocytes, donor3	11688-122I5	47.42	0.79	1.38	1.38	0.40	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	120.89	8.79	0.00	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	70.12	4.31	1.08	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	71.74	3.92	1.85	1.38	0.23	0.12
Lens Epithelial Cells, donor3	11690-122I7	86.28	8.27	1.41	3.83	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	50.75	17.79	1.07	2.25	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	32.93	7.81	1.12	0.56	1.95	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	41.56	12.28	1.10	0.63	0.79	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	38.18	11.83	0.54	0.54	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	32.15	7.88	0.95	0.95	0.63	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	42.69	11.32	1.08	0.75	0.65	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	33.65	9.03	0.82	0.41	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	38.43	10.11	1.01	0.51	1.26	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	41.66	9.57	1.27	0.84	0.56	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	29.27	1.98	0.00	0.40	0.79	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	38.58	10.66	1.36	0.78	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	38.33	11.66	1.67	0.56	0.56	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	40.07	7.32	0.35	1.39	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	36.02	10.97	0.95	0.72	0.72	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	38.32	11.54	0.82	1.24	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	35.11	7.39	0.31	0.92	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	29.93	7.79	0.94	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	44.47	11.53	0.91	1.83	1.46	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	37.19	9.54	0.99	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	37.49	6.74	0.88	0.88	0.59	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	51.78	13.94	1.49	1.00	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	38.31	9.21	0.00	1.45	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	27.20	8.89	1.62	0.27	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	43.14	13.02	1.51	1.21	0.76	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	31.10	6.22	1.04	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	36.02	7.96	0.42	0.42	0.63	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	46.62	7.67	1.20	0.60	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	36.46	11.01	1.38	1.38	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	32.93	7.34	0.19	0.38	0.56	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	47.50	11.88	1.27	0.74	0.85	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	27.14	7.75	1.94	0.00	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	23.82	6.62	0.33	0.66	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	44.97	12.14	0.62	0.99	0.50	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	44.43	9.26	0.37	1.11	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	27.92	9.14	0.49	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	43.04	11.55	0.82	0.82	0.41	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	37.31	6.75	0.64	0.64	0.32	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	29.82	6.70	0.30	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	43.39	11.06	0.56	1.12	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	36.62	7.47	1.42	0.71	0.36	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	26.18	7.27	0.97	0.00	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	45.28	11.51	0.47	0.78	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	37.24	10.74	1.07	0.72	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	40.51	9.15	0.33	0.98	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	34.61	10.59	0.94	0.94	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	47.27	16.34	0.99	1.11	0.37	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	29.45	7.43	0.51	0.26	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	42.96	10.44	0.90	0.60	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	83.84	4.53	4.53	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	133.48	6.90	3.84	3.07	6.14	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	110.59	4.45	3.71	3.71	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	124.40	3.81	4.23	1.27	2.12	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	137.85	7.03	3.52	2.81	3.52	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	129.82	4.67	4.67	1.87	0.93	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	124.70	4.64	2.58	1.03	2.58	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	117.76	5.95	2.38	5.95	2.38	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	109.25	3.85	2.71	2.26	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	97.43	5.23	2.04	2.04	1.74	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	117.50	5.40	3.15	4.95	1.35	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	136.71	6.77	4.20	2.57	1.08	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	104.25	6.16	1.03	2.57	1.54	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	116.44	5.65	2.12	4.23	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	112.61	2.00	4.66	2.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	117.67	3.57	2.55	0.00	4.08	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	129.93	4.80	4.27	4.54	2.67	1.07
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	122.06	6.05	3.21	3.21	2.08	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	98.78	4.29	0.61	0.00	1.84	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	136.99	8.15	5.71	5.71	4.89	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	111.83	5.00	2.92	3.54	2.08	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	118.83	5.04	1.68	2.80	4.48	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	128.79	8.24	2.06	7.21	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	125.99	6.97	2.90	3.48	5.52	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	100.14	6.88	1.79	1.79	2.39	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	128.91	6.64	1.66	3.87	2.77	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	137.51	9.19	4.24	2.12	4.60	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	113.58	5.90	1.84	2.21	3.32	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	123.19	5.76	0.00	1.15	3.45	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	118.58	4.22	4.22	2.30	1.15	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	133.61	8.49	1.70	1.70	5.66	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	132.92	6.56	4.92	4.10	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	128.33	4.07	3.62	2.71	2.71	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	122.08	4.31	2.87	2.87	5.75	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	127.72	3.73	5.23	4.48	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	145.66	5.95	4.46	6.69	5.20	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	117.59	3.02	3.02	1.29	3.45	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	137.01	5.99	4.28	2.57	3.43	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	143.27	5.00	3.00	5.33	4.00	2.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	142.38	10.26	3.02	1.81	2.41	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	138.64	8.53	3.55	2.13	2.84	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	130.27	5.50	2.75	2.06	2.75	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	133.11	4.83	4.83	1.61	4.29	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	129.29	8.75	2.69	2.69	4.04	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	147.42	9.26	1.48	2.59	3.33	1.48
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	106.99	3.49	5.81	4.65	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	122.70	5.29	4.23	2.12	4.23	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	152.86	6.00	3.20	3.60	3.60	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	115.57	5.09	2.91	2.91	1.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	107.31	3.83	6.13	6.90	3.07	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	128.75	7.40	2.96	4.93	3.95	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	107.27	6.59	1.88	0.94	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	115.65	6.03	2.01	5.03	1.01	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	115.81	5.41	4.51	2.25	2.70	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	117.04	6.88	1.72	0.00	1.72	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	129.15	6.23	2.67	4.45	3.12	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	123.56	6.26	3.91	4.30	2.35	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	102.92	4.62	2.64	2.64	1.98	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	140.11	8.30	2.59	3.11	4.15	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	148.77	3.06	3.06	2.19	3.50	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	101.20	5.59	4.47	2.80	1.12	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	118.36	4.86	3.09	4.42	0.88	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	130.37	6.94	3.47	1.93	1.93	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	115.96	6.58	3.54	3.04	2.53	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	131.21	4.33	3.84	2.88	1.44	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	125.23	7.16	1.59	2.78	1.59	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	106.33	3.04	1.22	1.82	3.04	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	95.45	2.77	2.08	2.77	2.08	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	124.26	8.36	3.42	3.04	2.66	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	120.84	5.68	2.07	2.07	2.58	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	113.68	6.65	3.63	1.81	2.42	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	128.98	6.34	2.85	2.54	5.39	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	117.81	5.33	3.20	1.07	0.53	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	117.23	5.75	3.45	2.87	1.72	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	113.13	4.11	2.57	5.14	2.06	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	130.86	3.54	2.12	0.71	2.12	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	136.76	2.84	5.11	3.40	2.27	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	130.22	7.07	4.99	3.33	3.74	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	127.64	8.61	1.57	1.57	1.57	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	127.77	5.43	4.18	3.34	2.09	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	130.10	4.65	1.86	2.32	3.25	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	127.79	4.01	0.67	1.34	5.35	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	147.56	5.88	1.60	3.74	1.07	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	158.00	7.27	6.06	4.85	4.45	1.62
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	142.25	3.67	0.92	1.84	2.75	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	168.04	3.56	0.89	3.56	3.56	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	137.34	3.99	4.56	3.99	5.70	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	131.91	2.30	5.37	4.60	2.30	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	138.98	4.92	1.64	1.64	2.74	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	171.50	12.47	3.56	3.12	4.01	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	182.23	5.72	3.38	3.90	1.30	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	153.84	5.30	2.65	2.65	3.32	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	149.66	6.24	2.08	8.31	4.16	0.00
Macrophage - monocyte derived, donor1	11232-116C8	83.87	7.29	1.60	2.51	0.68	0.23
Macrophage - monocyte derived, donor2	11313-117C8	77.26	6.24	1.10	3.12	0.55	0.00
Macrophage - monocyte derived, donor3	11389-118C3	94.51	7.73	2.62	1.84	1.44	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	80.72	4.25	3.72	1.06	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	114.88	5.55	1.58	1.27	0.79	0.00
Mallassez-derived cells, donor3	11930-125I4	127.31	6.67	2.78	1.39	1.39	0.00
Mammary Epithelial Cell, donor1	11273-116H4	74.04	1.69	1.20	1.30	0.60	0.00
Mammary Epithelial Cell, donor2	11350-117G9	88.02	3.19	2.03	0.87	2.32	0.00
Mammary Epithelial Cell, donor3	11422-118F9	80.07	5.99	1.00	1.25	0.50	0.00
Mast cell - stimulated, donor1	11487-119E2	70.51	12.20	0.00	1.36	0.00	0.00
Mast cell, donor1	11563-120D6	54.39	5.84	6.06	7.57	0.22	0.00
Mast cell, donor2	11565-120D8	46.36	4.75	5.65	5.65	0.89	0.30
Mast cell, donor3	11566-120D9	58.76	5.40	5.18	5.40	0.45	0.00
Mast cell, donor4	11567-120E1	45.74	3.72	7.98	5.14	0.89	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	48.02	2.44	4.44	2.22	0.55	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	23.93	1.17	0.00	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	47.61	3.21	2.18	2.18	0.11	0.11
Mast cell, expanded, donor8	11941-126A6	44.69	5.02	3.18	2.34	0.33	0.00
Melanocyte - dark, donor1	11502-119F8	61.69	22.09	2.69	2.59	0.40	0.30
Melanocyte - dark, donor2	11582-120F7	74.75	7.96	1.04	1.04	1.04	0.00
Melanocyte - dark, donor3	11663-122F7	103.45	5.36	3.11	2.90	0.36	0.22
Melanocyte - light, donor1	11274-116H5	93.56	2.35	2.82	2.35	0.00	0.00
Melanocyte - light, donor2	11351-117H1	91.45	3.41	3.41	2.05	0.00	0.68
Melanocyte - light, donor3	11423-118G1	65.91	3.47	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	97.04	2.92	2.19	1.04	1.25	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	86.06	3.77	2.15	1.88	1.61	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	106.34	4.29	1.87	1.61	1.61	0.27
Meningeal Cells, donor1	11493-119E8	150.73	12.28	3.60	2.85	0.12	0.00
Meningeal Cells, donor2	11573-120E7	116.20	6.60	1.32	1.76	0.88	0.00
Meningeal Cells, donor3	11654-122E7	74.17	5.54	2.04	1.22	0.65	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	87.83	4.56	3.71	1.71	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	41.46	2.72	1.11	0.60	0.00	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	64.39	1.31	5.26	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	94.19	1.31	3.92	1.31	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	49.51	4.31	2.15	4.31	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	78.57	4.87	1.48	0.64	0.64	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	66.35	1.01	0.50	0.00	1.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	106.58	4.61	3.30	0.88	0.88	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	94.98	7.31	1.46	1.46	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	94.94	3.68	1.43	2.25	0.82	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	60.11	2.91	1.39	0.69	0.42	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	79.18	3.72	0.74	1.12	1.12	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	50.79	2.76	0.92	0.13	0.39	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	54.60	1.48	0.89	0.59	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	46.71	2.34	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	93.50	4.48	1.28	2.56	1.92	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	74.08	3.19	1.77	1.06	0.71	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	61.92	2.81	0.63	0.31	0.31	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	60.23	2.90	0.00	0.73	2.18	0.73
Mesothelial Cells, donor1	11247-116E5	114.56	7.42	2.65	2.12	0.80	0.27
Mesothelial Cells, donor2	12156-128G5	124.12	7.01	2.50	1.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	111.07	7.30	1.37	2.60	0.79	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	113.43	9.45	2.70	2.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	115.26	6.16	4.68	2.22	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	102.47	3.53	1.18	2.65	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	124.45	0.00	3.46	6.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	82.14	3.41	2.48	2.48	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	89.61	4.15	2.49	0.62	1.04	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	129.70	0.00	6.95	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	105.11	5.51	1.25	2.25	0.25	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	127.08	6.05	2.33	3.72	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	175.20	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	89.41	4.27	3.86	2.64	1.22	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	84.74	1.98	3.17	0.40	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	128.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	63.72	5.31	1.77	1.77	2.65	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	87.01	5.70	2.66	4.18	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	115.80	3.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	75.13	5.52	1.06	2.12	1.49	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	61.70	2.76	2.76	3.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	60.51	3.58	2.38	3.58	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	97.25	1.68	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	33.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	60.72	5.27	2.26	2.51	1.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	100.06	6.18	2.14	2.61	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	110.02	1.66	3.87	3.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	74.37	4.14	1.61	1.61	0.46	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	88.76	4.00	0.63	1.89	0.21	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	62.37	3.06	1.63	3.06	0.20	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	72.73	2.79	1.29	2.79	0.86	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	92.25	3.78	2.22	1.56	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	92.87	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	68.33	3.72	1.10	1.31	0.44	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	101.39	6.59	4.56	2.53	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	101.08	4.97	0.00	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	78.82	4.08	1.63	1.09	0.54	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	93.22	4.41	1.76	2.06	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	97.04	1.09	4.36	3.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	84.10	3.36	0.48	1.92	0.48	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	96.05	4.80	0.80	3.20	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	94.61	4.11	5.48	2.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	86.10	7.01	3.00	3.50	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	130.46	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	97.22	3.50	1.31	1.31	1.31	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	135.75	3.31	0.00	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	103.10	3.20	1.28	2.56	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	116.77	4.21	1.24	1.98	1.24	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	102.99	4.87	4.18	2.78	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	179.00	8.84	2.21	4.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	125.81	6.50	1.71	2.74	2.39	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	122.97	2.63	0.88	1.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	140.97	2.49	3.20	1.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	132.42	3.93	3.09	1.40	1.40	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	125.10	3.74	2.08	2.08	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	120.05	5.24	1.75	4.08	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	109.81	5.13	1.81	1.51	1.51	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	127.72	2.92	3.76	2.92	0.42	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	216.56	0.00	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	110.83	2.77	0.00	0.00	0.92	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	157.65	3.41	1.71	1.14	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	137.35	6.36	2.07	1.24	0.55	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	111.69	6.48	1.30	1.81	0.78	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	135.99	6.43	3.43	1.29	0.43	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	131.48	6.99	0.64	2.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	104.35	4.00	1.07	1.87	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	146.07	6.59	2.69	1.80	0.90	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	106.79	4.52	1.70	1.41	0.85	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	104.47	7.33	0.64	0.64	1.59	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	158.11	7.30	2.21	2.21	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	126.27	5.31	1.90	1.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	126.43	3.41	1.70	2.84	0.85	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	152.64	5.41	2.46	2.70	1.23	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	138.81	5.87	1.30	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	114.67	2.35	2.06	1.18	0.88	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	164.92	5.19	0.86	2.02	1.15	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	136.42	8.24	0.00	1.65	0.00	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	125.07	5.36	2.38	1.49	0.89	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	26.37	0.00	0.00	3.77	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	46.34	3.56	1.78	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	94.63	8.21	2.96	2.30	1.64	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	64.17	1.05	2.10	2.10	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	56.54	1.58	0.99	1.19	0.99	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	79.16	1.86	0.93	1.86	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	70.22	4.88	3.76	0.00	1.50	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	68.72	4.79	2.66	1.60	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	76.34	5.54	1.24	1.24	0.34	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	71.46	3.68	2.21	2.21	2.95	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	79.51	2.20	0.37	0.37	0.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	76.22	6.22	3.11	1.56	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	46.50	2.14	0.53	0.53	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	34.78	3.86	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	95.94	5.05	2.02	2.02	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	41.74	2.53	0.84	0.42	0.84	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	36.77	0.00	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	43.23	4.45	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	68.03	2.43	2.43	0.81	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	31.72	1.51	1.51	0.00	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	62.81	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	71.77	6.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	99.80	4.75	9.50	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	88.11	3.45	1.51	0.43	1.08	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	54.87	0.00	0.52	1.57	0.52	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	20.69	3.34	0.00	0.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	30.47	2.09	1.25	1.25	0.83	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	69.59	3.61	2.85	1.52	1.33	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	75.01	1.60	0.00	3.19	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	9.52	0.00	1.36	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	73.51	1.84	5.51	1.84	3.68	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	6.70	0.42	0.42	0.42	0.00	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	30.91	2.56	0.70	0.23	0.70	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	16.48	1.08	0.27	0.27	1.35	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	43.94	2.31	0.42	0.63	0.21	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	100.21	22.27	11.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	32.26	0.99	0.00	0.50	1.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	35.46	0.81	0.54	0.81	0.54	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	14.51	0.45	0.00	0.00	0.68	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	19.27	0.65	0.00	0.33	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	43.38	1.46	0.55	0.91	0.55	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	18.57	0.53	0.00	0.00	1.06	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	20.41	1.20	0.00	0.00	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	42.33	1.64	0.33	1.64	0.66	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	12.52	0.98	0.16	0.33	0.81	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	42.16	2.47	0.71	0.35	0.53	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	10.55	2.81	0.70	0.70	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	14.25	0.00	0.00	0.46	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	11.57	0.32	0.00	0.32	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	66.56	2.07	4.14	2.76	2.07	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	189.63	17.70	10.11	2.53	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	43.67	1.78	1.11	0.67	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	19.05	0.42	0.85	0.00	1.27	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	25.87	0.95	0.71	0.95	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	8.16	0.43	0.00	0.43	1.29	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	216.67	18.06	0.00	9.03	18.06	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	17.99	1.67	0.67	0.00	1.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	36.07	0.45	0.00	1.35	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	11.51	0.00	0.00	0.00	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	19.50	0.93	0.00	0.93	0.93	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	28.76	2.65	0.76	0.76	0.38	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	22.49	0.65	0.00	0.33	0.33	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	16.12	0.00	0.44	2.18	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	38.44	1.81	0.90	1.36	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	5.29	0.00	0.00	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	9.31	0.66	0.00	0.66	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	16.87	0.50	0.00	1.49	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	12.63	0.77	0.77	0.00	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	37.50	1.21	0.91	0.30	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	47.08	1.55	0.88	0.22	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	8.13	0.68	0.00	0.00	2.03	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	76.64	0.00	10.22	0.00	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	16.46	1.22	1.22	1.22	1.83	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	27.38	1.89	0.31	0.00	0.94	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	23.00	0.00	0.30	0.61	0.61	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	9.49	0.79	0.79	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	54.41	1.13	1.13	2.27	1.13	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	60.69	0.00	5.06	0.00	5.06	0.00
Myoblast, donor1	11241-116D8	84.23	3.60	1.86	2.11	1.12	0.25
Myoblast, donor2	11322-117D8	69.04	3.26	2.69	2.11	1.92	0.96
Myoblast, donor3	11398-118D3	70.12	4.04	2.02	2.19	0.34	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	44.36	2.63	4.96	3.21	1.02	0.00
Natural Killer Cells, donor1	11230-116C6	41.82	8.30	6.77	1.85	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	28.95	4.22	5.73	2.41	0.90	0.00
Natural Killer Cells, donor3	11387-118C1	36.63	7.91	6.81	3.50	0.18	0.00
Neural stem cells, donor1	11275-116H6	113.24	9.80	2.18	1.45	0.00	0.00
Neural stem cells, donor2	11352-117H2	154.05	21.18	1.93	1.93	1.93	0.00
Neurons, donor1	11494-119E9	116.07	13.65	2.28	2.28	3.41	0.00
Neurons, donor2	11574-120E8	129.24	15.85	3.52	2.86	0.66	0.00
Neurons, donor3	11655-122E8	69.88	4.11	0.82	0.82	0.82	0.82
Neutrophils, donor1	11233-116C9	97.44	16.70	8.35	2.78	0.93	0.00
Neutrophils, donor2	11314-117C9	101.46	14.49	0.00	0.00	0.00	5.80
Neutrophils, donor3	11390-118C4	115.45	33.60	4.28	6.72	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	72.43	3.92	1.78	1.19	0.83	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	47.86	2.28	0.65	0.65	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	58.36	3.21	1.80	1.80	1.40	0.20
Olfactory epithelial cells, donor1	11933-125I7	27.94	2.48	0.83	0.14	0.28	0.14
Olfactory epithelial cells, donor2	11934-125I8	42.27	2.03	0.43	0.58	2.46	0.87
Olfactory epithelial cells, donor3	11935-125I9	41.54	1.25	0.11	0.45	0.57	0.11
Olfactory epithelial cells, donor4	11936-126A1	51.82	1.27	0.88	0.39	0.49	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	112.54	6.02	1.81	0.60	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	64.45	2.13	1.70	1.70	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	48.01	0.00	2.29	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	27.93	1.86	3.72	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	106.51	6.06	2.15	0.59	0.00	0.00
Osteoblast, donor2	11354-117H4	94.81	7.02	2.11	0.70	1.40	0.00
Osteoblast, donor3	11426-118G4	113.39	6.93	1.60	2.67	1.07	0.36
Pancreatic stromal cells, donor1	11249-116E7	83.73	3.79	2.44	2.11	0.51	0.08
Pericytes, donor1	11491-119E6	109.49	4.34	3.00	1.34	0.33	0.00
Pericytes, donor2	11571-120E5	88.96	5.66	2.04	2.26	1.13	0.23
Pericytes, donor3	11652-122E5	100.71	4.48	1.22	0.81	1.83	0.41
Perineurial Cells, donor1	11499-119F5	73.58	5.20	1.47	1.58	0.11	0.11
Perineurial Cells, donor2	11579-120F4	82.53	8.47	2.12	2.67	0.74	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	65.02	10.52	2.87	2.87	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	41.38	4.16	1.71	2.45	0.73	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	51.25	10.74	4.66	2.98	0.39	0.13
Placental Epithelial Cells, donor1	11278-116H9	43.77	1.43	1.20	0.72	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	58.77	2.22	0.00	1.11	2.22	0.00
Placental Epithelial Cells, donor3	11427-118G5	56.15	3.53	0.20	1.18	0.20	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	50.63	0.95	0.63	0.32	4.11	0.32
Preadipocyte - breast, donor1	11467-119B9	54.03	2.44	0.56	0.75	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	55.47	3.39	1.04	2.09	0.26	0.00
Preadipocyte - breast, donor2	11328-117E5	61.02	3.15	1.58	2.03	2.48	0.45
Preadipocyte - omental, donor1	11468-119C1	59.14	2.34	0.64	0.85	0.43	0.11
Preadipocyte - omental, donor2	11329-117E6	70.71	5.24	2.62	2.62	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	93.54	5.87	1.72	1.86	0.29	0.00
Preadipocyte - perirenal, donor1	11469-119C2	62.99	1.97	1.97	0.00	0.98	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	88.76	3.99	1.54	2.15	0.61	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	93.14	5.31	2.12	1.77	2.48	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	94.17	3.92	1.19	2.04	1.53	0.34
Preadipocyte - visceral, donor1	11280-116I2	88.30	3.45	2.51	1.58	0.37	0.00
Preadipocyte - visceral, donor2	11357-117H7	91.58	4.14	1.38	0.46	1.38	0.00
Preadipocyte - visceral, donor3	11429-118G7	75.55	3.55	0.94	1.99	1.99	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	147.53	4.22	1.36	0.91	2.26	0.15
Prostate Epithelial Cells, donor2	11331-117E8	84.50	5.55	1.22	1.35	1.08	0.54
Prostate Epithelial Cells, donor3	11404-118D9	71.89	1.29	1.59	1.59	1.10	0.06
Prostate Stromal Cells, donor1	11254-116F3	101.94	4.21	1.14	1.14	0.11	0.11
Prostate Stromal Cells, donor2	11332-117E9	95.92	5.92	1.61	2.33	0.90	0.90
Prostate Stromal Cells, donor3	11405-118E1	78.31	3.13	2.29	1.77	1.36	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	116.79	3.28	2.92	2.55	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	70.63	3.33	1.73	0.76	0.42	0.21
Renal Epithelial Cells, donor1	11517-119H5	143.04	2.54	2.54	2.03	1.01	0.00
Renal Epithelial Cells, donor2	11597-120H4	120.21	5.69	2.13	0.71	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	77.49	2.75	0.95	0.21	0.85	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	67.40	16.34	2.04	4.77	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	76.01	10.78	2.16	2.96	0.94	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	83.70	11.10	2.00	2.00	1.78	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	67.88	21.96	1.33	0.00	1.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	125.67	7.92	2.20	1.54	1.32	0.00
Renal Mesangial Cells, donor2	11598-120H5	95.30	10.03	1.88	0.63	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	120.67	4.44	1.94	1.11	1.39	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	145.75	7.78	1.88	1.34	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	104.58	3.80	1.27	1.27	0.84	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	113.59	5.79	1.35	1.35	0.96	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	64.04	1.81	1.30	2.59	0.26	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	83.28	4.26	3.41	0.00	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	94.68	3.09	2.06	2.06	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	59.21	1.76	1.00	0.25	0.50	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	69.49	5.61	2.27	1.60	0.27	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	99.17	1.79	0.00	0.00	0.89	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	44.58	4.40	0.00	0.55	1.10	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	129.35	3.48	0.00	0.00	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	120.01	8.84	1.56	0.52	0.52	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	84.01	7.55	0.60	0.50	1.69	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	100.72	11.49	1.00	0.45	0.45	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	129.13	13.40	1.98	2.73	0.87	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	90.79	8.62	1.05	0.93	2.91	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	102.16	9.01	0.92	0.46	2.08	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	103.09	7.39	0.68	0.96	1.23	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	87.13	6.20	1.21	0.91	1.66	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	90.49	7.17	1.08	0.36	0.54	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	109.89	8.46	0.57	1.43	1.43	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	85.53	7.83	0.75	1.07	3.43	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	90.28	8.19	0.44	1.11	1.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	97.69	5.16	1.15	0.57	0.57	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	85.71	8.29	1.21	0.37	1.12	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	106.17	9.77	1.13	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	103.51	9.29	1.59	1.86	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	91.99	9.73	1.36	0.88	2.43	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	93.57	8.02	0.76	0.57	1.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	97.50	9.18	0.75	0.96	0.53	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	84.93	6.73	0.56	0.00	1.96	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	100.15	9.23	0.51	0.34	1.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	89.71	6.75	0.73	0.36	0.55	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	86.58	7.60	1.59	0.86	1.84	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	105.17	11.28	1.48	0.81	2.15	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	112.51	6.84	0.94	0.71	1.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	89.68	5.75	1.39	0.00	1.79	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	92.84	9.82	2.10	0.70	1.17	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	100.36	7.88	1.24	1.24	0.83	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	91.58	6.64	0.88	0.44	3.76	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	96.09	9.61	1.46	0.00	0.42	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	106.59	8.08	0.13	0.81	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	79.36	7.66	1.02	1.02	0.51	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	92.93	9.45	1.16	0.96	0.77	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	98.69	5.33	2.06	0.52	0.69	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	68.31	7.27	1.65	1.23	0.69	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	89.14	8.37	0.82	0.49	1.81	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	99.36	5.79	1.02	0.68	1.19	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	100.02	10.50	1.33	0.89	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	83.16	8.80	1.33	1.33	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	96.51	8.57	1.24	1.52	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	96.19	9.29	0.48	1.19	0.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	93.52	9.67	0.81	1.01	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	92.10	9.61	1.32	0.47	0.47	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	61.14	8.04	0.70	0.70	1.75	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	65.28	5.74	1.51	0.30	1.21	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	97.17	10.04	1.22	1.47	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	113.82	11.79	1.46	0.58	0.58	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	77.88	13.99	0.61	1.22	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	106.39	10.85	1.51	0.90	0.90	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	76.45	10.18	1.36	0.45	1.36	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	78.48	5.99	0.60	0.90	1.50	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	82.30	10.98	1.06	0.12	0.94	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	77.05	5.98	0.43	0.43	1.28	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	85.34	5.41	0.00	0.00	0.60	0.00
Schwann Cells, donor1	11498-119F4	111.90	10.16	1.32	2.26	1.50	0.56
Schwann Cells, donor2	11578-120F3	68.05	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	56.52	6.13	1.75	0.88	0.88	0.22
Sebocyte, donor1	11220-116B5	211.99	8.22	4.38	2.74	0.55	0.00
Sebocyte, donor2	11301-117B5	130.51	6.89	2.30	2.76	1.38	2.30
Sebocyte, donor3	11378-118B1	105.32	5.77	1.24	4.33	1.24	0.00
Sertoli Cells, donor1	11255-116F4	102.71	9.94	1.66	4.97	1.66	0.00
Sertoli Cells, donor2	11333-117F1	81.91	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	71.44	3.34	1.58	0.79	0.26	0.00
Skeletal Muscle Cells, donor2	11358-117H8	35.42	0.00	0.00	1.45	1.45	0.00
Skeletal Muscle Cells, donor3	11430-118G8	111.19	7.52	2.51	3.34	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	70.06	2.98	1.26	1.41	0.79	0.16
Skeletal Muscle Cells, donor5	11455-119A6	63.17	2.68	1.64	1.64	1.78	0.30
Skeletal Muscle Cells, donor6	11459-119B1	69.72	3.54	1.69	1.69	1.54	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	69.05	2.27	2.14	1.13	1.01	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	71.49	3.42	1.71	2.28	1.43	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	93.46	5.75	1.88	2.48	0.89	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	66.64	4.63	1.35	0.93	0.59	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	72.38	4.34	1.45	1.45	1.45	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	85.86	6.19	2.61	2.20	0.55	0.41
Skin - palm, donor1	10286-104F7	110.13	5.37	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	48.87	2.88	0.72	0.29	1.59	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	81.79	7.36	1.64	0.00	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	49.46	2.73	1.30	0.13	1.30	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	87.44	2.64	0.97	0.42	0.14	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	69.06	4.22	1.13	1.41	1.55	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	100.01	6.98	1.69	2.33	0.42	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	85.29	3.07	1.95	1.57	0.97	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	93.50	2.78	2.16	1.54	0.93	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	82.48	2.22	1.11	1.56	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	99.34	4.11	2.94	2.94	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	114.03	6.41	3.31	1.33	1.10	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	127.98	7.48	2.36	1.18	0.39	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	99.66	7.73	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	36.03	2.00	0.00	0.00	0.00	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	103.14	6.65	2.40	1.60	0.27	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	75.58	3.10	1.99	1.33	0.66	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	119.71	7.94	1.66	3.46	1.02	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	67.07	2.28	2.60	0.33	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	72.35	6.79	2.66	1.18	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	75.31	4.13	1.14	1.28	1.85	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	97.93	3.58	1.95	1.14	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	48.10	0.61	2.13	0.30	0.91	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	84.86	4.04	2.53	1.52	0.51	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	140.78	6.12	12.24	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	93.46	3.81	3.34	1.43	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	63.41	1.18	1.18	0.44	0.44	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	64.79	3.44	0.86	1.08	1.72	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	77.35	4.62	1.05	1.57	1.26	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	128.38	6.81	2.47	0.93	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	200.49	7.55	2.16	4.31	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	108.48	7.17	1.20	2.39	1.20	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	115.05	6.49	3.07	2.05	0.34	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	54.97	2.28	0.94	0.63	0.08	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	93.60	4.83	3.32	1.81	0.30	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	121.51	10.01	1.37	2.96	2.50	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	116.54	7.25	0.60	3.62	2.42	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	91.40	6.62	2.65	2.12	0.26	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	102.13	5.19	2.13	1.86	0.27	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	89.91	3.26	1.88	2.75	1.13	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	40.59	2.28	1.27	1.01	0.25	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	104.64	6.33	2.41	0.90	0.30	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	96.02	4.50	3.00	1.50	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	268.78	14.21	15.51	5.17	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	114.41	4.65	4.19	0.47	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	131.77	13.63	1.01	3.53	2.02	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	99.66	7.83	2.82	3.13	1.57	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	75.81	3.83	1.18	1.18	0.59	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	80.06	4.92	1.75	2.25	0.08	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	51.85	3.27	2.80	0.93	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	106.36	5.90	1.87	1.15	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	97.14	10.45	2.04	2.29	0.76	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	87.44	8.09	1.13	1.88	0.94	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	73.23	5.45	1.82	1.54	0.42	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	68.87	6.28	1.09	2.01	0.67	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	40.95	1.90	0.48	1.90	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	100.31	7.34	1.71	1.47	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	93.46	4.20	2.43	2.65	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	74.02	4.10	2.34	2.34	0.59	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	48.01	1.17	1.17	0.19	0.58	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	79.07	1.85	0.53	0.26	0.79	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	41.66	1.12	1.49	0.37	2.60	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	85.16	1.08	2.52	0.00	1.44	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	104.19	1.70	1.14	0.28	0.28	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	47.66	0.79	1.97	0.79	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	66.79	1.02	0.51	0.76	1.27	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	53.91	0.80	0.80	0.40	0.80	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	48.49	0.84	3.34	0.00	0.84	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	55.00	1.38	0.92	0.00	0.92	0.00
Synoviocyte, donor1	11291-117A4	80.46	4.88	0.50	0.84	0.17	0.17
Synoviocyte, donor2	11368-117I9	55.65	2.68	1.17	2.18	0.50	0.17
Synoviocyte, donor3	11440-118H9	50.71	2.46	0.45	1.12	0.89	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	144.72	9.29	3.93	1.43	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	91.17	5.95	0.00	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	93.54	5.33	1.16	2.08	1.16	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	88.10	2.37	1.43	1.08	0.22	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	78.86	3.48	3.09	1.93	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	81.32	2.29	0.57	1.72	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	67.91	5.66	2.83	1.60	0.74	0.00
Urethra, donor2	10319-105A4	75.53	1.80	0.00	1.80	0.00	1.80
Urothelial Cells, donor1	11520-119H8	121.14	4.52	2.66	1.33	1.59	0.00
Urothelial Cells, donor2	11600-120H7	89.73	3.61	0.00	0.40	0.80	0.00
Urothelial Cells, donor3	11681-122H7	75.64	3.21	1.38	1.38	0.69	0.46
Urothelial cells, donor0	11216-116B1	89.83	3.34	1.56	0.67	0.45	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	109.44	18.69	9.79	2.67	0.89	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	144.39	25.73	14.30	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	72.56	15.06	4.11	4.11	4.11	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	71.62	7.23	5.85	2.41	0.69	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	63.91	8.72	4.65	1.16	0.58	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	102.04	20.82	9.37	6.25	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	121.15	18.36	5.51	3.67	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	74.86	15.52	3.65	4.56	0.91	0.91
Wilms' tumor cell line:G-401	10809-111A8	100.17	8.14	2.34	1.23	0.49	0.25
Wilms' tumor cell line:HFWT	10597-108E3	49.28	1.76	0.88	0.88	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	73.46	1.96	1.68	1.12	0.56	0.00
achilles tendon, donor2	10292-104G4	86.79	2.07	4.13	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	87.45	9.43	3.57	3.31	0.76	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	74.53	4.41	3.25	4.64	0.46	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	50.45	4.15	2.73	1.42	0.47	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	95.51	15.24	3.81	2.99	1.90	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	69.43	21.64	1.41	1.69	1.12	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	54.77	35.11	0.42	1.27	1.48	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	61.79	35.93	1.91	0.54	0.82	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	62.57	14.98	3.53	0.88	2.20	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	92.70	37.16	2.45	0.41	3.27	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	107.56	19.41	3.11	2.33	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	59.98	11.78	1.29	0.74	1.29	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	237.93	27.30	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	84.82	35.09	1.39	1.39	0.93	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	121.42	9.06	3.62	1.55	1.29	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	133.56	10.81	1.46	1.75	1.75	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	135.71	8.37	3.72	1.86	0.93	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	88.01	23.44	0.41	0.00	2.47	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	27.63	3.68	0.61	0.61	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	73.39	5.12	2.56	1.28	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	81.28	6.67	0.91	0.91	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	86.17	5.78	1.68	1.20	0.48	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	213.83	27.84	4.01	2.45	2.67	0.89
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	126.41	5.34	3.00	1.00	0.67	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	94.77	9.29	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	99.44	34.28	2.26	2.64	0.75	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	100.75	27.91	2.62	0.87	2.18	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	101.22	43.11	0.00	5.62	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	67.59	0.71	1.41	1.41	0.24	0.24
adipose tissue, adult, pool1	10010-101C1	64.99	5.89	3.26	2.48	0.62	0.47
adipose, donor1	10184-103D4	232.80	17.01	4.10	3.52	1.17	1.76
adipose, donor2	10185-103D5	36.90	3.65	0.41	1.22	0.41	0.00
adipose, donor3	10186-103D6	90.67	3.27	2.45	2.18	0.27	0.27
adipose, donor4	10187-103D7	247.89	5.20	6.93	3.47	0.87	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	113.16	1.42	4.73	3.16	0.16	0.16
adrenal gland, adult, pool1	10081-102A9	32.74	0.00	3.64	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	53.76	3.74	3.20	1.73	0.27	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	98.26	1.79	3.22	3.22	0.71	0.00
amniotic membrane cells, donor1	12235-129G3	49.62	2.32	2.09	2.09	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	62.89	2.37	1.35	2.03	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	63.04	2.06	5.01	3.24	0.88	0.00
amygdala - adult, donor10196	10167-103B5	442.30	13.04	20.16	15.42	2.37	0.00
amygdala, adult, donor10252	10151-102I7	303.75	16.22	15.61	21.90	1.82	1.01
amygdala, newborn, donor10223	10360-105E9	253.70	12.59	3.87	2.90	0.65	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	55.26	3.82	1.02	0.51	0.25	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	76.56	4.19	2.43	2.21	0.66	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	89.52	6.01	1.00	1.00	0.33	0.00
aorta, adult, pool1	10052-101G7	62.57	4.12	4.51	2.75	0.39	0.39
appendix, adult	10189-103D9	82.28	2.72	5.43	2.33	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	95.27	3.10	3.10	2.75	0.34	0.00
artery, adult	10190-103E1	39.40	0.00	0.00	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	120.53	7.97	1.16	0.43	1.16	0.14
b cell line:RPMI1788	10427-106D4	81.04	1.93	2.97	2.68	0.30	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	85.73	5.83	1.39	0.83	0.55	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	123.54	5.06	2.88	1.69	0.40	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	72.81	1.84	1.67	1.34	0.17	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	74.94	7.83	1.68	2.24	0.00	0.00
bladder, adult, pool1	10011-101C2	61.82	2.93	3.04	2.39	0.54	0.00
blood, adult, pool1	10053-101G8	53.15	8.86	2.21	8.86	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	73.65	6.85	0.86	5.99	0.00	0.00
bone marrow, adult	10192-103E3	55.34	7.42	1.35	2.02	0.67	0.67
brain, adult, donor1	10084-102B3	242.94	15.38	12.30	17.43	5.13	0.00
brain, adult, pool1	10012-101C3	358.91	18.04	24.39	16.70	3.12	0.56
brain, fetal, pool1	10085-102B4	256.45	37.40	2.67	21.37	5.34	0.00
breast carcinoma cell line:MCF7	10482-107A5	144.70	10.57	4.29	1.65	1.32	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	148.16	5.37	3.74	1.62	0.37	0.37
breast, adult, donor1	10080-102A8	27.15	1.89	0.00	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	100.36	3.81	2.16	2.29	0.89	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	88.44	6.80	1.24	1.86	1.55	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	78.04	2.07	2.30	1.61	2.30	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	819.22	23.97	10.41	13.07	8.47	1.45
carcinoid cell line:NCI-H1770	10703-109H1	55.01	2.82	0.47	0.00	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	89.15	3.83	2.41	1.20	0.44	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	51.97	4.75	0.63	0.32	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	63.62	2.13	0.80	1.33	1.60	0.27
caudate nucleus - adult, donor10196	10177-103C6	264.80	9.21	12.66	10.36	3.45	0.00
caudate nucleus, adult, donor10252	10164-103B2	349.21	14.56	20.41	24.43	1.34	0.67
caudate nucleus, adult, donor10258	10379-105H1	461.54	11.46	13.75	18.34	3.06	0.76
caudate nucleus, newborn, donor10223	10354-105E3	321.92	11.35	3.66	2.56	2.20	0.73
cerebellum - adult, donor10196	10173-103C2	101.96	5.83	17.48	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	145.19	10.46	11.74	13.88	1.07	0.21
cerebellum, adult, pool1	10083-102B2	81.06	7.59	10.69	11.04	2.07	0.34
cerebellum, newborn, donor10223	10357-105E6	142.81	8.30	2.49	1.66	0.83	0.00
cerebral meninges, adult	10188-103D8	403.93	9.58	19.16	14.88	3.03	0.76
cerebrospinal fluid, donor2	10294-104G6	64.32	1.46	2.92	2.92	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	71.17	1.87	1.15	0.58	0.14	0.00
cervical cancer cell line:ME-180	10553-107I4	120.81	4.47	2.65	1.33	0.50	0.17
cervix, adult, pool1	10013-101C4	84.83	7.24	3.57	2.20	1.36	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	81.10	4.88	2.51	1.95	0.98	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	56.17	1.31	2.61	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	105.76	4.10	1.62	0.87	1.12	0.00
choriocarcinoma cell line:SCH	10785-110H2	151.80	1.97	3.08	2.34	0.99	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	77.56	1.66	1.19	0.95	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	67.81	4.27	2.56	2.85	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	102.02	6.46	2.29	2.68	0.50	0.10
chorionic membrane cells, donor3	12240-129G8	91.76	2.20	3.30	3.30	2.20	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	37.36	12.12	1.01	2.02	2.02	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	49.75	16.71	1.54	1.73	1.73	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	56.81	14.99	1.48	3.17	0.42	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	63.17	1.80	1.28	0.51	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	65.07	2.66	0.73	1.45	0.00	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	66.17	2.65	1.63	1.02	0.81	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	68.31	1.77	2.36	0.29	0.29	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	54.21	10.43	1.82	0.52	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	82.98	3.20	1.14	0.91	2.97	1.60
clear cell carcinoma cell line:TEN	10636-108I6	86.75	2.26	1.04	2.78	0.52	0.35
colon carcinoma cell line:CACO-2	10513-107D9	215.81	8.05	3.29	2.20	0.92	0.00
colon carcinoma cell line:COLO-320	10420-106C6	131.89	3.80	3.04	2.28	0.76	0.00
colon, adult, donor1	10082-102B1	66.64	5.95	2.38	7.14	0.00	0.00
colon, adult, pool1	10014-101C5	96.35	3.64	4.70	2.12	0.59	0.00
colon, fetal, donor1	10070-101I7	41.41	1.85	0.62	1.85	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	96.25	45.84	4.58	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	80.31	3.40	0.85	1.27	0.85	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	128.44	9.36	1.66	1.06	1.06	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	134.95	11.28	2.54	1.27	0.71	0.00
corpus callosum, adult, pool1	10042-101F6	210.84	8.51	16.03	11.94	0.66	0.00
cruciate ligament, donor2	10295-104G7	72.13	1.62	2.43	1.62	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	20.06	4.82	0.80	0.00	0.00	0.00
diencephalon, adult	10193-103E4	190.79	6.96	12.24	13.44	1.20	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	60.85	3.67	1.84	2.76	2.07	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	271.83	5.90	3.33	1.54	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	51.27	1.69	0.96	1.20	0.96	0.00
ductus deferens, adult	10196-103E7	90.20	6.48	1.99	1.50	1.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	34.57	1.44	0.00	4.32	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	91.22	3.68	3.68	0.74	2.21	1.47
dura mater, adult, donor1	10041-101F5	158.24	11.73	5.86	4.46	0.50	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	56.18	2.22	1.33	0.67	0.22	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	68.06	3.01	2.01	1.43	1.00	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	88.79	3.70	3.08	3.08	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	84.15	1.82	0.61	2.12	0.30	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	105.90	3.09	1.23	1.23	0.62	0.00
embryonic pancreas cell line:2C6	10603-108E9	112.96	7.88	3.94	3.94	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	206.82	11.40	2.68	1.34	0.34	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	82.64	1.99	2.17	1.09	0.54	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	92.63	3.54	1.61	1.77	3.06	0.32
epidermoid carcinoma cell line:A431	10426-106D3	127.61	5.11	2.11	1.33	0.22	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	91.95	4.84	2.42	1.32	0.77	0.00
epididymis, adult	10197-103E8	92.52	3.56	3.56	1.05	1.47	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	51.80	3.19	0.53	0.89	0.35	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	93.20	1.18	0.39	0.39	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	121.88	6.42	1.44	2.49	1.44	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	139.26	7.09	3.25	1.67	1.18	0.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	140.04	5.04	2.69	2.35	1.23	0.56
esophagus, adult, pool1	10015-101C6	77.93	3.61	3.82	3.08	0.53	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	153.54	5.39	2.63	1.63	0.75	0.13
eye - muscle inferior rectus, donor1	10272-104E2	74.85	0.00	4.83	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	42.08	6.31	0.00	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	56.55	0.00	5.95	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	63.06	1.15	1.15	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	69.95	2.91	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	66.61	6.86	4.07	3.81	2.03	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	61.16	5.13	1.28	1.03	1.54	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	99.48	4.04	1.66	1.66	0.47	0.24
frontal lobe, adult, pool1	10040-101F4	505.99	23.08	25.71	17.64	2.16	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	128.51	6.91	1.80	1.80	1.50	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	81.93	9.78	1.19	1.01	0.64	0.00
gall bladder, adult	10198-103E9	105.26	2.41	5.55	2.66	2.17	0.24
gamma delta positive T cells, donor1	11937-126A2	32.75	5.91	5.91	1.61	1.07	0.00
gamma delta positive T cells, donor2	11938-126A3	34.73	6.72	4.48	2.24	0.75	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	147.01	7.18	3.17	2.11	4.22	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	97.87	2.51	1.93	3.67	0.19	0.00
gastric cancer cell line:AZ521	10549-107H9	174.28	6.07	5.57	3.44	0.98	0.16
gastric cancer cell line:GSS	10560-108A2	63.15	0.92	0.00	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	58.26	3.20	0.91	0.23	0.69	0.00
giant cell carcinoma cell line:LU65	10487-107B1	20.65	0.23	0.57	0.34	0.23	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	88.73	7.56	2.24	1.54	0.14	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	131.69	2.24	2.00	2.49	0.50	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	80.33	6.23	1.27	1.16	0.11	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	75.56	7.30	1.40	1.54	0.42	0.00
glioblastoma cell line:T98G	10485-107A8	72.52	7.17	1.21	1.32	0.66	0.11
glioma cell line:GI-1	10413-106B8	80.54	7.03	1.46	0.88	0.88	0.00
globus pallidus - adult, donor10196	10175-103C4	140.68	5.10	6.56	4.37	2.92	0.00
globus pallidus, adult, donor10252	10161-103A8	171.35	13.43	14.16	10.50	0.49	0.24
globus pallidus, adult, donor10258	10367-105F7	110.91	5.48	6.85	5.48	0.00	4.11
globus pallidus, newborn, donor10223	10364-105F4	174.80	5.86	2.66	1.07	0.53	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	176.19	63.63	7.34	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	76.50	32.79	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	83.63	26.13	0.00	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	82.24	2.88	1.28	0.64	1.60	0.32
hIPS +CCl2, biol_rep1	14383-156B9	147.83	3.67	4.59	0.92	0.92	0.00
hIPS +CCl2, biol_rep2	14384-156C1	167.82	3.66	1.83	1.37	2.74	0.46
hIPS +CCl2, biol_rep3	14385-156C2	186.79	5.15	1.29	0.64	1.93	0.00
hIPS, biol_rep1	14380-156B6	169.60	0.00	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	152.95	2.74	1.37	0.00	4.12	0.69
hIPS, biol_rep3	14382-156B8	257.11	4.41	16.55	3.31	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	60.05	2.30	2.59	2.01	0.86	0.57
heart - mitral valve, adult	10205-103F7	52.32	3.29	1.79	1.79	0.60	0.30
heart - pulmonic valve, adult	10206-103F8	57.26	1.05	2.35	1.31	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	84.93	6.66	4.16	1.67	3.33	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	61.42	2.65	2.65	1.63	1.02	0.00
heart, adult, diseased, donor1	10051-101G6	46.42	2.98	2.98	1.70	0.00	0.00
heart, adult, pool1	10016-101C7	54.27	3.68	4.14	1.15	0.23	0.00
heart, fetal, pool1	10046-101G1	64.28	6.88	1.54	2.46	0.31	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	79.60	4.32	0.31	0.62	1.23	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	72.54	5.95	1.19	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	63.98	5.52	1.33	1.55	0.33	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	75.13	5.22	1.46	2.06	0.85	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	77.41	4.85	0.91	1.92	0.61	0.10
hepatoma cell line:Li-7	10484-107A7	139.91	6.45	1.22	0.56	0.78	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	133.16	8.64	2.51	2.31	0.90	0.20
hippocampus - adult, donor10196	10169-103B7	320.80	9.46	7.57	8.52	1.89	0.00
hippocampus, adult, donor10252	10153-102I9	257.37	17.76	14.49	16.33	1.63	0.61
hippocampus, adult, donor10258	10374-105G5	527.33	9.46	17.93	4.98	3.49	0.00
hippocampus, newborn, donor10223	10363-105F3	268.24	14.10	5.64	3.88	0.35	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	165.40	9.16	2.44	0.61	6.10	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	104.66	8.05	0.98	1.57	2.16	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	123.90	3.55	1.78	1.52	2.29	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	96.98	2.82	0.56	1.69	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	84.95	4.13	0.77	1.29	7.75	1.81
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	118.44	2.66	1.52	0.76	1.52	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	81.75	4.67	0.29	0.29	2.04	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	70.66	5.82	1.51	1.29	0.86	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	75.91	5.00	1.25	0.00	0.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	66.30	5.92	0.95	0.24	0.71	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	63.64	4.34	0.80	0.48	1.45	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	71.37	2.69	0.00	0.67	1.35	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	134.58	9.23	3.13	0.63	3.76	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	139.53	6.88	3.44	1.47	7.37	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	150.11	8.73	0.87	0.00	6.11	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	135.74	6.68	1.34	1.72	3.44	0.76
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	117.74	7.85	1.74	0.44	4.36	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	131.44	6.50	1.00	0.00	3.50	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	64.05	2.26	1.13	0.75	0.94	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	53.20	1.82	1.36	0.45	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	60.45	1.25	0.94	0.00	0.63	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	59.28	4.74	1.80	0.49	0.65	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	68.22	4.64	1.16	0.58	1.74	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	70.55	3.89	0.30	0.30	1.79	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	107.71	6.28	1.48	0.37	2.77	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	102.99	9.41	2.57	0.57	1.71	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	180.07	8.98	2.04	0.82	4.08	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	152.45	6.69	2.46	1.41	6.69	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	101.04	5.07	1.58	1.58	3.80	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	139.81	4.24	2.42	0.91	2.42	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	81.19	5.17	0.52	1.55	1.55	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	64.42	5.31	1.99	0.00	1.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	87.99	4.36	1.03	0.26	0.51	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	79.25	8.44	1.53	1.79	2.81	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	74.21	6.06	0.76	0.76	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	74.60	6.72	0.34	1.01	1.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	119.55	6.76	1.69	2.42	2.90	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	126.12	5.79	1.34	0.45	1.78	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	126.34	9.27	1.95	0.98	0.49	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	123.78	4.28	1.53	0.61	2.14	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	292.79	13.01	3.25	6.51	22.77	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	132.38	4.30	0.99	0.99	2.65	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	53.64	3.28	0.55	2.19	1.64	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	74.91	2.90	0.00	0.72	1.81	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	61.92	1.07	0.71	0.00	0.71	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	59.67	4.77	0.00	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	85.45	4.88	2.03	0.95	0.41	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	55.50	1.89	0.27	0.27	0.27	0.00
immature langerhans cells, donor1	11904-125F5	89.59	17.68	2.18	1.21	0.73	0.00
immature langerhans cells, donor2	11905-125F6	79.21	15.05	0.00	0.79	0.79	0.00
insula, adult, pool1	10039-101F3	640.01	30.38	29.34	23.37	2.46	0.57
keratoacanthoma cell line:HKA-1	10791-110H8	80.96	2.93	1.95	1.63	0.33	0.00
kidney, adult, pool1	10017-101C8	134.47	6.91	4.21	3.20	0.60	0.10
kidney, fetal, pool1	10045-101F9	123.58	9.83	3.40	3.96	1.06	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	183.06	12.21	5.96	3.69	0.57	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	43.41	1.66	1.24	1.24	0.69	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	96.15	2.02	1.47	2.20	0.18	0.18
left atrium, adult, donor1	10079-102A7	23.43	3.27	0.54	1.63	1.09	0.00
left ventricle, adult, donor1	10078-102A6	18.71	1.52	1.01	1.01	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	73.33	2.19	1.64	1.64	0.00	0.27
leiomyoma cell line:10964C	10569-108B2	97.72	3.23	2.16	1.44	3.59	1.08
leiomyoma cell line:15242A	10570-108B3	90.76	3.80	1.09	2.72	2.72	0.54
leiomyoma cell line:15425	10571-108B4	96.16	4.13	2.67	3.64	3.16	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	69.84	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	61.69	4.18	1.05	2.09	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	76.97	12.16	1.30	0.83	0.83	0.12
liposarcoma cell line:KMLS-1	10782-110G8	61.86	1.41	1.87	1.41	0.31	0.00
liposarcoma cell line:SW 872	10726-110A6	88.94	9.38	1.10	1.46	0.61	0.24
liver, adult, pool1	10018-101C9	85.73	3.08	3.24	1.30	0.81	0.00
liver, fetal, pool1	10086-102B5	29.16	1.88	0.00	1.88	1.88	0.00
locus coeruleus - adult, donor10196	10182-103D2	114.76	3.35	5.98	4.81	0.29	0.44
locus coeruleus, adult, donor10252	10165-103B3	156.31	9.23	9.23	12.18	1.29	0.18
locus coeruleus, adult, donor10258	10375-105G6	93.39	2.54	6.49	3.39	5.08	1.41
locus coeruleus, newborn, donor10223	10362-105F2	121.14	1.68	4.21	1.68	1.26	0.42
lung adenocarcinoma cell line:A549	10499-107C4	73.35	1.52	0.97	0.97	0.42	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	144.78	15.86	2.07	5.52	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	174.00	13.45	0.66	2.64	1.32	0.40
lung, adult, pool1	10019-101D1	89.54	8.15	4.13	3.43	0.47	0.24
lung, fetal, donor1	10068-101I5	154.69	18.84	5.42	4.28	0.57	0.00
lung, right lower lobe, adult, donor1	10075-102A3	46.28	5.96	0.46	1.83	0.46	0.46
lymph node, adult, donor1	10077-102A5	49.23	2.37	2.84	2.37	1.42	0.47
lymphangiectasia cell line:DS-1	10727-110A7	57.86	7.67	2.41	1.32	0.66	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	56.75	2.87	4.23	3.17	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	182.64	8.49	2.55	4.25	0.85	0.00
mature adipocyte, donor1	12231-129F8	73.70	1.78	3.11	2.22	0.00	0.00
mature adipocyte, donor2	12232-129F9	68.48	1.87	3.53	1.45	0.83	0.21
mature adipocyte, donor3	12233-129G1	67.33	3.32	2.61	2.37	0.95	0.00
mature adipocyte, donor4	12234-129G2	63.96	2.63	3.42	1.84	0.00	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	114.84	4.53	3.57	1.91	0.24	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	338.41	19.18	18.05	16.92	3.38	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	267.22	14.16	20.60	20.05	1.10	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	291.64	9.85	16.84	5.72	6.04	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	481.08	19.19	10.66	5.54	8.53	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	318.60	15.19	10.13	13.16	14.34	2.87
medial temporal gyrus, adult, donor10252	10156-103A3	262.10	17.19	14.64	15.70	0.21	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	358.28	15.41	11.56	3.85	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	789.45	14.35	100.48	100.48	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	334.52	12.92	7.18	2.51	1.79	1.08
medulla oblongata - adult, donor10196	10174-103C3	73.33	1.30	5.19	1.95	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	129.11	7.74	8.05	9.91	0.46	0.46
medulla oblongata, adult, pool1	10038-101F2	232.80	9.71	16.90	10.61	0.82	0.16
medulla oblongata, newborn, donor10223	10361-105F1	124.64	5.90	2.08	2.43	2.08	0.00
medulloblastoma cell line:D283 Med	10838-111E1	67.31	4.65	1.11	0.00	1.77	0.44
medulloblastoma cell line:ONS-76	10759-110E3	56.12	3.91	0.49	1.35	0.49	0.12
melanoma cell line:COLO 679	10514-107E1	87.54	6.18	0.43	0.72	0.29	0.00
melanoma cell line:G-361	10465-106H6	64.88	1.63	1.36	1.09	0.81	0.00
meningioma cell line:HKBMM	10691-109F7	34.01	1.63	1.27	1.27	2.17	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	127.77	9.69	0.88	1.76	2.64	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	120.02	10.63	3.11	1.56	1.56	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	103.57	5.22	1.84	6.44	1.23	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	73.26	4.18	0.73	2.00	0.91	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	84.89	5.38	3.31	3.31	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	81.19	4.07	2.11	3.37	0.84	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	87.43	3.08	2.70	3.08	0.96	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	74.96	4.86	2.08	1.39	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	79.81	3.43	1.20	3.26	1.37	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	98.68	4.03	3.57	3.80	1.15	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	112.21	8.62	2.79	1.86	1.33	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	121.94	8.37	1.62	3.65	1.49	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	119.64	7.97	2.70	4.27	1.28	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	54.34	1.98	1.32	0.33	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	111.53	7.47	1.52	1.80	1.94	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	100.19	2.09	1.40	1.75	1.40	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	88.20	4.29	1.43	4.29	1.63	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	70.81	3.24	0.72	0.72	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	83.17	5.59	1.55	1.66	0.83	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	89.60	2.28	0.68	1.82	2.51	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	170.76	7.97	2.52	3.78	1.68	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	89.66	6.43	2.54	1.64	1.94	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	90.86	6.91	1.75	4.03	1.23	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	63.32	3.31	0.37	0.74	1.47	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	73.54	2.29	1.14	1.14	1.43	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	70.73	2.53	2.11	1.26	2.53	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	63.02	2.74	1.37	0.46	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	58.83	2.05	1.02	0.51	0.77	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	62.30	1.83	1.57	1.31	0.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	63.77	2.77	1.54	0.92	0.92	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	55.78	2.12	0.94	0.94	0.94	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	61.26	1.35	0.68	1.02	1.35	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	59.34	1.96	0.39	0.79	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	57.92	2.32	1.39	0.46	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	68.35	3.17	1.73	0.87	1.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	66.48	2.68	1.78	1.56	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	65.62	2.88	1.44	1.44	0.72	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	76.27	6.60	2.93	2.93	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	55.38	4.36	1.01	1.01	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	63.04	2.05	0.82	1.23	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	59.71	2.58	1.29	0.86	0.86	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	51.95	0.00	0.00	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	41.32	5.16	0.00	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	57.16	1.30	0.65	0.00	0.97	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	55.29	0.00	0.00	2.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	51.18	2.13	0.53	0.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	47.43	0.82	0.00	0.82	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	53.25	1.55	1.17	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	52.47	4.20	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	51.66	1.99	0.99	0.99	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	33.37	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	37.36	1.19	1.78	0.00	1.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	47.52	1.22	1.22	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	50.04	0.63	0.00	0.00	1.27	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	40.35	0.69	0.34	0.34	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	42.98	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	35.93	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	27.55	3.44	0.00	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	28.52	1.63	0.41	0.81	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	27.81	0.00	0.79	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	21.22	0.59	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	21.20	0.62	0.62	0.00	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	32.08	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	30.75	2.37	1.18	2.37	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	33.38	0.00	5.14	2.57	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	44.75	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	87.09	1.98	1.48	0.00	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	69.53	0.00	0.00	1.12	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	52.79	0.64	0.64	0.00	1.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	122.91	6.04	1.61	1.61	2.82	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	122.11	8.72	8.72	2.18	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	110.23	3.80	1.27	2.53	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	57.65	1.82	0.61	0.61	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	63.27	0.00	0.00	0.00	9.04	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	41.18	1.65	0.00	0.82	2.47	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	29.57	2.18	0.79	0.40	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	41.86	0.65	0.65	0.65	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	46.86	3.06	1.02	4.07	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	83.56	4.64	0.00	2.32	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	101.35	1.89	2.36	1.65	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	153.37	9.27	2.78	1.16	0.70	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	123.93	12.82	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	54.97	4.01	0.41	0.41	1.54	0.00
mesothelioma cell line:Mero-25	10850-111F4	117.11	5.67	0.45	0.00	1.13	0.68
mesothelioma cell line:Mero-41	10851-111F5	139.84	6.11	1.22	0.49	2.69	0.00
mesothelioma cell line:Mero-48a	10852-111F6	97.21	4.87	2.44	0.44	1.33	0.22
mesothelioma cell line:Mero-82	10853-111F7	84.89	4.47	1.58	1.05	0.53	0.00
mesothelioma cell line:Mero-83	10854-111F8	66.56	3.92	1.70	0.68	1.02	0.34
mesothelioma cell line:Mero-84	10855-111F9	106.92	4.55	0.76	1.01	2.27	0.00
mesothelioma cell line:Mero-95	10856-111G1	104.97	8.28	1.66	1.04	2.07	1.04
mesothelioma cell line:NCI-H2052	10847-111F1	96.90	6.79	1.66	0.99	0.50	0.33
mesothelioma cell line:NCI-H226	10846-111E9	161.26	11.22	1.27	0.90	1.81	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	95.32	3.59	1.88	1.20	1.54	0.17
mesothelioma cell line:NCI-H28	10845-111E8	68.20	1.53	1.02	0.76	1.27	0.00
mesothelioma cell line:No36	10857-111G2	80.25	3.26	2.28	0.33	0.33	0.65
mesothelioma cell line:ONE58	10858-111G3	105.40	7.59	2.17	0.27	0.54	0.00
migratory langerhans cells, donor1	11901-125F2	106.71	5.76	4.80	2.69	1.34	0.00
migratory langerhans cells, donor2	11902-125F3	128.71	6.23	3.54	2.08	0.73	0.12
migratory langerhans cells, donor3	11903-125F4	122.41	5.38	2.87	1.08	0.36	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	79.33	2.29	0.98	0.33	2.94	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	68.24	4.66	0.85	0.85	1.27	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	64.73	2.76	1.61	1.84	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	48.33	2.85	2.28	0.95	0.76	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	75.95	6.47	2.03	1.66	0.74	0.00
myeloma cell line:PCM6	10474-106I6	61.87	4.15	2.37	0.79	0.20	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	94.36	1.52	2.54	1.52	1.01	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	71.98	4.12	3.73	2.16	0.20	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	50.03	0.67	1.00	1.89	0.45	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	50.30	0.44	1.03	1.10	0.29	0.00
nasal epithelial cells, donor2	12227-129F4	91.63	1.66	2.21	4.97	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	84.89	7.36	1.38	0.92	0.46	0.00
neuroblastoma cell line:NB-1	10539-107G8	81.76	9.54	2.62	1.68	0.37	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	79.93	8.22	0.84	1.27	0.21	0.21
neuroblastoma cell line:NH-12	10555-107I6	68.95	4.85	0.93	2.05	0.19	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	50.05	4.51	0.00	0.95	0.24	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	85.84	5.54	1.43	4.12	1.27	0.63
neuroectodermal tumor cell line:TASK1	10774-110F9	41.06	1.21	0.00	0.20	0.20	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	76.93	3.81	0.64	1.91	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	56.16	3.46	0.53	1.33	0.53	0.27
neutrophil PMN, donor1	12133-128D9	119.00	0.00	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	39.84	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	104.18	9.47	0.00	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	52.93	4.74	3.55	3.89	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	115.27	17.61	5.60	4.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	58.35	4.17	0.96	0.32	0.96	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	82.51	4.73	0.26	1.05	3.15	0.00
nucleus accumbens, adult, pool1	10037-101F1	543.41	25.87	29.62	24.37	1.97	0.37
occipital cortex - adult, donor10196	10172-103C1	263.73	8.24	14.42	8.24	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	207.44	11.81	13.69	16.37	0.54	0.54
occipital cortex, newborn, donor10223	10355-105E4	373.41	26.20	3.28	4.73	2.91	1.09
occipital lobe, adult, donor1	10076-102A4	325.90	27.03	14.17	16.53	5.77	1.84
occipital lobe, fetal, donor1	10073-102A1	190.52	18.88	2.57	9.44	0.86	0.86
occipital pole, adult, pool1	10036-101E9	476.12	26.33	32.72	23.42	2.52	0.00
olfactory region, adult	10195-103E6	309.89	11.27	13.95	17.19	1.53	0.38
optic nerve, donor1	10277-104E7	136.07	0.00	6.00	4.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	83.15	2.39	1.82	1.03	0.34	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	81.33	1.37	1.79	0.96	0.14	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	96.51	2.37	1.35	2.20	2.88	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	140.69	3.93	3.23	2.77	1.16	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	63.50	2.65	0.29	0.59	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	111.19	7.47	2.80	1.87	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	98.82	8.91	1.27	1.27	0.42	0.00
ovary, adult, pool1	10020-101D2	72.33	4.02	4.37	2.53	0.26	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	60.86	4.95	2.20	1.47	0.73	0.00
pancreas, adult, donor1	10049-101G4	74.31	1.88	3.76	1.88	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	68.77	0.84	0.56	0.84	0.56	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	70.53	5.62	1.70	0.34	2.56	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	98.52	3.81	1.82	0.83	0.83	0.00
paracentral gyrus, adult, pool1	10035-101E8	472.62	24.62	32.12	21.97	2.01	0.09
parietal cortex, adult, donor10258	10373-105G4	350.12	9.54	8.81	5.87	8.07	1.47
parietal lobe - adult, donor10196	10171-103B9	244.53	15.05	11.29	9.40	2.82	1.88
parietal lobe, adult, donor10252	10157-103A4	266.22	10.26	17.67	18.24	1.71	0.57
parietal lobe, adult, pool1	10034-101E7	464.83	23.62	32.34	22.91	1.50	0.26
parietal lobe, fetal, donor1	10072-101I9	145.48	13.58	3.88	4.85	2.91	0.00
parietal lobe, newborn, donor10223	10356-105E5	384.33	17.57	6.73	1.87	1.87	0.75
parotid gland, adult	10199-103F1	79.55	6.17	1.23	1.85	0.62	0.00
penis, adult	10200-103F2	51.03	1.61	2.15	0.54	2.15	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	18.04	0.37	0.37	0.00	0.37	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	130.98	6.70	2.48	2.19	1.89	0.15
pineal gland - adult, donor10196	10179-103C8	153.52	6.45	10.32	6.45	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	193.06	8.88	14.81	17.17	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	187.50	3.76	8.15	5.64	2.51	0.63
pituitary gland - adult, donor10196	10180-103C9	211.47	10.12	8.09	4.05	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	268.41	14.59	13.03	12.51	1.56	0.00
pituitary gland, adult, donor10258	10378-105G9	167.69	10.21	3.40	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	75.25	5.59	3.01	3.33	0.86	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	91.11	1.85	2.38	2.25	0.53	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	59.61	8.72	0.93	2.49	0.16	0.00
pons, adult, pool1	10033-101E6	252.87	10.41	21.26	14.46	1.03	0.17
postcentral gyrus, adult, pool1	10032-101E5	507.27	23.36	31.03	25.11	2.09	0.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	129.67	31.37	8.37	6.27	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	66.10	22.03	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	23.47	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	89.87	3.35	1.75	1.89	0.87	0.15
prostate cancer cell line:PC-3	10439-106E7	135.40	9.44	3.81	2.54	1.27	0.18
prostate, adult, pool1	10022-101D4	71.01	5.62	5.35	2.72	0.18	0.00
putamen, adult, donor10196	10176-103C5	548.38	26.91	26.68	42.49	4.01	1.89
putamen, adult, donor10252	10152-102I8	374.50	7.84	17.65	11.76	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	318.01	10.93	2.19	1.09	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	470.90	13.29	20.78	13.77	4.83	0.48
putamen, newborn, donor10223	10365-105F5	128.19	3.75	3.00	0.00	2.25	3.00
rectal cancer cell line:TT1TKB	10469-106I1	96.01	2.33	2.62	2.04	0.00	0.00
rectum, fetal, donor1	10067-101I4	73.72	4.17	1.39	4.17	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	89.04	5.94	0.85	0.85	2.33	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	53.85	2.49	0.83	0.41	1.24	0.00
retina, adult, pool1	10030-101E3	126.34	6.16	8.15	4.57	0.80	0.00
retinoblastoma cell line:Y79	10475-106I7	68.59	3.90	1.82	0.52	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	117.91	5.53	2.95	2.58	0.86	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	119.23	12.65	1.69	0.56	1.41	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	68.21	3.03	1.52	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	72.51	2.27	1.46	1.13	0.97	0.16
salivary acinar cells, donor2	11772-123I8	60.58	2.48	2.20	0.55	0.96	0.28
salivary acinar cells, donor3	11773-123I9	94.67	3.97	1.32	1.99	0.00	0.00
salivary gland, adult, pool1	10093-102C3	124.69	8.58	8.58	4.00	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	64.50	1.10	2.02	1.52	0.51	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	56.90	0.94	2.70	2.70	0.24	0.12
seminal vesicle, adult	10201-103F3	86.24	6.88	1.06	3.17	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	141.63	7.77	3.64	3.40	2.67	1.46
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	66.93	4.03	1.51	1.51	1.76	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	111.39	10.04	1.00	1.00	2.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	101.01	4.84	2.01	1.21	1.75	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	121.91	4.53	4.42	2.10	0.88	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	141.28	4.26	2.45	2.97	1.03	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	12.77	0.00	0.00	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	21.59	1.68	1.56	0.60	0.12	0.00
skeletal muscle, fetal, donor1	10066-101I3	24.12	6.03	1.01	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	27.14	0.00	0.00	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	73.85	5.68	1.26	1.89	1.26	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	246.14	22.01	4.00	4.34	1.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	62.41	5.04	1.58	0.95	1.89	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	173.28	1.54	3.47	1.54	2.70	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	119.17	11.70	3.79	2.47	0.33	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	76.24	1.61	1.13	0.97	0.64	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	69.08	6.76	1.31	2.62	0.87	0.00
small intestine, adult, pool1	10024-101D6	124.10	6.93	6.09	3.58	0.72	0.12
small intestine, fetal, donor1	10064-101I1	39.56	2.95	1.72	1.47	0.00	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	94.89	11.80	3.08	4.62	1.54	1.54
smooth muscle, adult, pool1	10048-101G3	51.43	3.10	4.14	2.33	0.52	1.03
somatostatinoma cell line:QGP-1	10781-110G7	81.75	6.97	2.68	0.80	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	81.90	3.67	2.52	4.59	0.69	0.69
spinal cord, adult, donor10252	10159-103A6	133.66	8.67	9.07	5.91	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	147.35	0.69	14.53	1.38	4.84	0.69
spinal cord, fetal, donor1	10056-101H2	190.88	12.20	6.10	12.20	1.83	1.22
spinal cord, newborn, donor10223	10359-105E8	146.95	3.67	6.43	2.76	3.21	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	74.38	4.03	0.75	0.90	1.19	0.00
spleen, adult, pool1	10025-101D7	75.33	7.49	4.19	3.19	0.33	0.22
spleen, fetal, pool1	10044-101F8	85.10	12.16	4.37	3.42	0.72	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	109.62	5.69	3.62	1.97	0.83	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	107.47	3.23	0.76	0.76	0.38	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	116.02	2.45	2.80	1.05	1.75	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	103.21	3.52	1.17	3.13	1.56	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	145.43	3.38	6.53	5.40	0.45	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	99.12	2.54	0.00	0.85	1.27	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	136.23	1.27	1.69	1.69	0.42	0.42
stomach, fetal, donor1	10062-101H8	59.81	7.48	3.20	4.27	0.00	1.07
submaxillary gland, adult	10202-103F4	73.49	3.42	1.71	1.14	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	162.82	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	109.46	6.02	9.35	11.01	0.83	0.21
substantia nigra, adult, donor10258	10371-105G2	227.07	2.59	12.41	1.55	2.07	0.00
substantia nigra, newborn, donor10223	10358-105E7	93.27	4.24	0.71	0.71	2.12	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	108.90	4.13	1.83	3.67	1.15	0.23
temporal lobe, adult, pool1	10031-101E4	576.10	29.50	30.01	24.07	3.98	0.42
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	235.76	25.64	4.99	11.40	1.42	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	246.58	16.26	3.96	1.76	0.88	1.32
tenocyte, donor1	11763-123H8	77.15	5.59	3.84	2.44	1.05	0.35
tenocyte, donor2	11765-123I1	52.27	1.91	0.76	3.43	0.76	0.38
tenocyte, donor3	11768-123I4	60.42	4.08	0.74	2.59	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	88.89	2.55	0.85	0.68	1.53	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	131.95	12.64	1.08	1.54	1.85	0.15
teratocarcinoma cell line:PA-1	10807-111A6	110.34	8.37	2.94	2.48	0.15	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	219.75	17.90	4.82	3.43	3.30	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	129.71	5.29	1.89	0.76	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	261.86	17.56	5.56	6.43	1.85	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	189.23	14.98	3.58	3.58	7.82	1.95
testis, adult, pool1	10026-101D8	106.08	4.51	6.76	5.05	1.18	0.11
testis, adult, pool2	10096-102C6	148.86	4.51	4.96	3.61	2.71	0.45
thalamus - adult, donor10196	10168-103B6	128.06	4.42	3.31	6.62	1.10	0.00
thalamus, adult, donor10252	10154-103A1	149.72	7.35	8.13	10.16	0.31	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	269.43	4.62	1.54	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	68.18	2.80	2.96	3.13	2.47	0.82
thalamus, newborn, donor10223	10366-105F6	129.45	5.18	6.90	2.30	0.58	0.00
throat, adult	10209-103G2	54.93	2.25	2.75	1.75	0.75	0.75
throat, fetal, donor1	10061-101H7	56.07	6.70	0.61	2.13	2.13	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	88.04	5.56	0.79	0.79	0.60	0.00
thymus, adult, pool1	10027-101D9	98.82	10.04	5.47	3.18	0.89	0.20
thymus, fetal, pool1	10043-101F7	103.18	9.97	3.84	3.12	0.42	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	77.91	3.46	0.93	0.53	1.73	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	49.59	2.51	0.84	0.98	0.42	0.00
thyroid, adult, pool1	10028-101E1	148.27	8.40	4.95	3.83	0.75	0.00
thyroid, fetal, donor1	10060-101H6	49.30	4.48	2.64	2.64	0.00	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	89.31	6.16	9.24	9.24	0.00	0.00
tongue, adult	10203-103F5	69.08	2.56	2.56	1.86	1.40	0.93
tongue, fetal, donor1	10059-101H5	25.62	5.52	0.39	0.79	0.79	0.00
tonsil, adult, pool1	10047-101G2	99.88	5.61	8.01	4.01	0.40	0.00
trachea, adult, pool1	10029-101E2	96.85	5.73	3.60	1.96	0.33	0.08
trachea, fetal, donor1	10058-101H4	35.01	3.46	1.54	3.08	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	83.25	1.42	2.83	1.77	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	87.44	6.38	1.52	1.01	0.51	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	83.36	1.41	1.57	1.72	1.10	0.16
tridermal teratoma cell line:HGRT	10694-109G1	57.08	5.71	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	117.07	4.57	2.29	3.13	0.51	0.00
umbilical cord, fetal, donor1	10057-101H3	41.73	8.35	6.26	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	108.52	6.14	6.14	2.90	0.51	0.00
uterus, fetal, donor1	10055-101H1	53.24	7.17	2.05	2.05	0.00	1.54
vagina, adult	10204-103F6	52.99	3.88	0.65	1.29	0.65	0.00
vein, adult	10191-103E2	56.77	5.48	3.29	2.19	0.66	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	89.72	3.74	2.40	2.40	0.80	0.00